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   Musculoskeletal  diseases  affect  over  half  of  the  United  States  population  aged  
18  or  older,  and  over  75%  of  individuals  65  and  older.  Despite  the  prevalence  and  
estimated  economic  burden  of  over  $795  billion,  little  is  known  about  the  basic  biology  
of  some  musculoskeletal  tissues,  nor  the  pathogenesis  of  certain  musculoskeletal  
disorders.  Understanding  the  biology  of  these  tissues,  as  well  as  the  mechanisms  by  
which  normal  physiological  functioning  is  lost  will  undoubtedly  aid  in  the  development  of  
treatment  strategies  that  help  patients  recover  and  return  to  normal  life.  The  aims  of  this  
body  of  work  was  to  i)  address  the  lack  of  knowledge  in  basic  tendon  biology  that  
restricts  our  ability  to  understand  cellular  and  molecular  changes  to  tendon  following  
loading,  and  ii)  address  the  mechanisms  of  the  accumulation  of  pathological  ectopic  
lipid  with  concomitant  atrophy  and  fibrosis,  termed  myosteatosis,  that  occurs  in  chronic  
rotator  cuff  injuries.  The  studies  in  this  dissertation  fill  in  considerable  gaps  in  the  
understanding  of  i)  basic  tendon  biology  and  the  role  of  the  transcription  factor,  
scleraxis,  in  adult  tendon  adaptation,  and  ii)  the  progression  and  consequences  of  
myosteatosis  on  muscle  metabolism  and  function.  Scleraxis  is  a  basic  helix-­loop-­helix  
transcription  factor  required  for  the  embryonic  formation  of  tendon,  but  it  was  not  known  
what  the  role  of  scleraxis  was  in  adult  tendon  growth.  We  show  that  scleraxis  is  
expressed  in  proliferative  tendon  fibroblasts,  and  is  required  for  the  proper  growth  and  
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adaptation  of  adult  tendon  to  mechanical  stimuli.  Additionally,  we  show  scleraxis  may  
have  a  critical  role  in  the  differentiation  of  tendon  progenitor  cells.  For  myosteatosis,  it  
was  not  known  how  lipid  accumulated  within  torn  rotator  cuff  muscles,  or  what  pathways  
were  activated  by  excess  lipid.  We  show  that  myosteatosis  arises  from  an  initial  acute  
inflammatory  phase  marked  by  dysfunctional  mitochondria  that  are  unable  to  oxidize  
lipid.  This  results  in  a  buildup  of  lipid  over  time,  which  results  in  a  chronic,  sustained  
inflammatory  environment,  marked  by  oxidative  stress,  atrophy,  and  muscle  
dysfunction.  Overall,  this  group  of  studies  establishes  several  new  directions  for  future  
research  that  apply  to  a  much  larger  body  of  musculoskeletal  disorders.    







BACKGROUND      
Musculoskeletal  injuries  and  disorders  affect  over  half  of  the  United  States  
population  over  the  age  of  18,  and  roughly  75%  of  individuals  65  and  older  (53).  Despite  
the  prevalence  and  an  estimated  economic  burden  of  over  $795  billion,  the  basic  
biology  of  certain  musculoskeletal  tissues,  nor  the  pathogenesis  of  certain  
musculoskeletal  disorders  was  not  known.  This  lack  in  knowledge  of  musculoskeletal  
issues  presents  a  great  opportunity  for  basic  research  into  both  the  physiological  
functioning  of  musculoskeletal  tissues,  and  identification  of  new  pathways  to  target  for  
treatment  of  musculoskeletal  disorders.  The  studies  in  this  dissertation  aimed  to  i)  
address  the  lack  of  knowledge  in  basic  tendon  biology  that  restricts  our  ability  to  
understand  cellular  and  molecular  changes  to  tendon  following  loading,  and  ii)  address  
the  mechanisms  of  the  accumulation  of  pathological  ectopic  lipid  with  concomitant  
atrophy  and  fibrosis,  termed  myosteatosis,  that  occurs  in  chronic  rotator  cuff  injuries.  
Prolonged  overloading  and  excessive  overuse  of  musculotendinous  structures  
leads  to  tissue  stress  and  often  bonafide  clinical  symptoms  (28).  Tendinopathies  are  
painful  disorders  that  can  occur  within  almost  any  tendon  in  the  body,  and  are  
degenerative  conditions  that  affect  tendon  cell  and  matrix  homeostasis  (27).  However,  
there  exists  a  gap  in  understanding  of  not  only  the  mechanisms  that  govern  
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tendinopathy,  but  also  the  basic  biology  or  physiology  of  tendon.  Virtually  nothing  is  
known  about  the  different  roles  of  tendon  fibroblasts  or  what  population  of  cells  
constitutes  the  tendon  stem  cell  compartment,  which  could  potentially  be  utilized  for  
therapies  to  treat  tendinopathies.  The  studies  described  in  this  dissertation  will  increase  
our  understanding  fundamental  tendon  biology  in  adulthood,  and  identify  the  
populations  of  cells  within  tendon  that  allow  this  tissue  to  grow  and  adapt  to  mechanical  
stimuli.  
Rotator  cuff  tears  account  for  the  majority  of  shoulder  injuries,  affecting  roughly  
4.5  million  patients  every  year,  and  are  accompanied  by  a  projected  annual  cost  of  $7  
billion  in  the  United  States  (25).  Over  a  quarter  million  rotator  cuff  surgeries  are  
performed  each  year  in  the  USA  (7),  yet  the  probability  of  re-­injury  after  surgery  can  be  
up  to  30%  in  moderate  to  severe  tears,  and  upwards  of  94%  for  massive,  chronic  tears  
(3).  The  incidence  and  severity  of  rotator  cuff  tears  increases  with  age,  and  almost  one  
quarter  of  individuals  over  50  have  complete  rupture  of  the  rotator  cuff  (32,  43).  The  
rotator  cuff  is  composed  of  four  muscles:  the  supraspinatus,  the  infraspinatus,  the  teres  
minor,  and  the  subscapularis  (Figure  1.1).  While  not  primary  movers  of  the  shoulder,  
these  muscles  play  a  vital  role  in  the  stabilization  of  the  shoulder  joint.  The  vast  majority  
of  rotator  cuff  tears  are  caused  over  long  periods  of  time  by  repetitive  micro-­trauma  to  
the  rotator  cuff  tendon  (54).  Tears  are  associated  with  irreversible  pathological  changes  
to  the  rotator  cuff  muscle,  and  while  surgical  repair  of  the  torn  rotator  cuff  offers  mild  
pain  relief  for  most  patients  (25),  the  repair  procedure  does  not  protect  muscle  tissue  
from  further  degradation  over  time.  Persistent  muscle  weakness  is  a  major  drawback  in  
the  ability  to  successfully  treat  these  injuries  and  reduce  patient  recovery  times  (16).  
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Because  surgical  repair  is  unable  to  fully  restore  the  function  of  the  rotator  cuff,  a  
deeper  understanding  of  the  cellular  and  molecular  changes  within  the  rotator  cuff  
following  tear  will  likely  augment  current  surgical  repair  techniques  and  treatment  of  
these  injuries.          
Like  many  other  unloading  models  of  muscle  injuries,  tears  cause  atrophy  and  
fibrosis  within  rotator  cuff  muscles.  However,  rotator  cuff  muscles  also  develop  a  
substantial  amount  of  intra-­  and  intermuscular  lipid  following  tear  (14,  16,  19),  and  
together  with  muscle  atrophy  and  fibrosis,  this  phenomenon  of  lipid  accumulation  within  
muscle  is  called  “myosteatosis.”  Surgical  repair  of  rotator  cuff  muscles  does  not  reduce  
myosteatosis  (15,  16),  and  the  amount  of  lipid  within  torn  rotator  cuff  muscles  is  
negatively  correlated  with  muscle  function  (14).  Since  the  initial  discovery  of  
myosteatosis  in  1852  (37),  numerous  studies  have  measured  accumulated  lipid  with  a  
variety  of  imaging  techniques  such  as  MRI,  and  while  many  postulate  that  the  
accumulated  lipid  in  myosteatosis  is  likely  pathological,  the  cellular  and  molecular  
mechanisms  that  account  for  the  reduction  in  muscle  function  following  myosteatosis  is  
unknown.  In  addition  to  the  studies  on  tendon  biology,  this  dissertation  will  identify  
pathways  that  are  involved  in  myosteatosis  that  lead  to  a  decrease  in  muscle  function  
and  lead  to  new  research  directions  in  the  field  of  myosteatosis.    
TENDON  STRUCTURE  AND  FUNCTION  
   Tendons  are  responsible  for  the  transmission  of  force  between  muscle  and  bone  
to  aid  in  movement.  This  tissue  is  primarily  composed  of  bundles  of  type  I  collagen  
fibers  arranged  in  cable  like  orientation  along  the  axis  of  force  transmission  (28,  55).  
Other  components  of  tendon  matrix  include  type  III  collagen,  elastin,  and  various  
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proteoglycans  such  as  decorin,  tenascin-­C,  fibromodulin,  and  biglycan  (28).  The  
fundamental  component  of  tendon  is  the  tendon  fiber,  which  combine  to  form  tendon  
fascicles,  and  further  organized  into  a  compartment  known  as  the  endotenon  by  layers  
of  type  IV  and  VI  collagens  (55).  These  structures  are  wrapped  with  a  basement  
membrane-­rich  matrix  known  as  the  epitenon,  which  contains  blood,  nerve,  and  
lymphatic  supply  for  the  tendon.  Finally,  the  outermost  tendon  layer  is  the  paratenon,  a  
synovial  sheath  that  encapsulates  the  epitenon  and  reduces  friction  for  the  tendon  as  it  
moves.  Together,  the  paratenon  and  epitenon  compose  the  peritenon.      
Tendon  is  often  exposed  to  a  wide  range  of  forces  during  movement,  and  the  
configuration  of  proteins  within  tendon  allow  for  the  proper  distribution  of  these  forces  to  
enable  movement.  The  biomechanics  of  tendon  are  often  measured  by  placing  loads  on  
tendon  and  measuring  stress  as  a  function  of  tendon  strain.  Stress  is  measured  as  the  
force  on  the  tissue  normalized  by  tendon  cross-­sectional  area  (CSA),  and  strain  is  
measured  by  the  deformation  of  the  tissue  normalized  by  its  resting  length  (33,  55).  The  
composition  of  tendon  makes  it  a  viscoelastic  material,  such  that  there  is  a  non-­linear  
relationship  between  stress  and  strain,  and  load  placed  on  the  tendon  to  stretch  it  can  
be  stored  within  the  tendon  to  be  released  as  elastic  energy.  A  linear  relationship  
between  stress  and  strain  is  observed  in  springs,  but  for  tendon,  loading  produces  a  
stress-­strain  relationship  that  is  marked  initially  by  a  shallow  toe  region,  and  upon  more  
loading  the  stress-­strain  curve  displays  a  more  linear  region  with  a  steeper  slope.  
Physiological  loading  typically  falls  within  the  toe  region  and  early  linear  region,  but  
upon  the  addition  of  more  load,  tendon  reaches  a  “yield  point,”  where  the  tendon  no  
longer  functions  within  the  normal  elastic  range.  Loading  tendons  past  the  yield  point  
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results  in  a  “plastic  range”  where  the  tendon  damage  is  permanent  and  the  tendon  is  
highly  susceptible  to  rupture  (33,  55).    
The  major  cellular  component  of  tendon  is  the  fibroblast,  which  sits  on  collagen  
fibers  and  contributes  to  tendon  matrix  synthesis,  degradation,  and  turnover  (28).  
Physiological  loading  of  tendons  can  increase  tendon  CSA,  fibroblast  density,  and  type  I  
collagen  levels  (27,  35,  38).  The  cellular  and  molecular  processes  that  govern  tendon  
adaptation  in  adulthood  are  largely  unknown,  but  in  other  tissues,  many  of  the  same  
signaling  pathways  and  molecular  networks  that  govern  musculoskeletal  tissue  
development  also  regulate  the  adaptation  of  these  tissues  in  adults  (13).  One  
transcription  factor  that  has  been  identified  with  a  central  role  in  tendon  development  is  
the  basic  helix-­loop-­helix  (bHLH)  transcription  factor  scleraxis  (8).  Scleraxis  robustly  
marks  limb  tendons  during  development,  and  loss  of  scleraxis  results  in  the  failure  to  
form  limb  tendons,  which  causes  limb  contractures  and  developmental  disabilities  (40,  
49).  Scleraxis  continues  to  be  widely  expressed  in  tendon  early  in  the  postnatal  stages  
of  life,  but  the  expression  is  limited  to  the  epitenon  region  in  adulthood  (35).    
In  the  adult  tendon,  scleraxis  likely  has  many  transcriptional  targets  important  for  
tendon  formation,  including  the  collagen  1α1  transcript  (31),  and  tenomodulin,  a  type  II  
transmembrane  glycoprotein  that  marks  differentiated  tendon  cells  (9,  51).  During  
physiological  loading  of  tendons,  scleraxis  levels  are  increased  in  the  epitenon  regions  
of  the  tendon,  which  also  correlates  with  increases  in  the  expression  of  tenomodulin  and  
type  I  collagen  transcripts  (35).  Not  much  is  known  about  the  role  of  scleraxis  in  the  
adaptation  of  adult  tendon,  or  if  scleraxis  is  required  for  the  increase  in  tendon  CSA  
following  mechanical  loading.  Additionally,  it  is  thought  that  tendon  possesses  a  stem  
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cell  compartment  (59),  but  the  location  of  these  cells,  and  whether  scleraxis  plays  a  role  
in  the  differentiation  of  these  cells  into  mature  tenocytes  is  unknown.    
SKELETAL  MUSCLE  STRUCTURE  AND  FUNCTION  
   Skeletal  muscle  is  composed  of  thousands  to  millions  of  long  multinucleated  
fibers  held  together  by  layers  of  ECM.  Like  tendon,  these  layers  of  ECM  are  arranged  in  
hierarchical  structure,  with  a  layer  of  endomysium  wrapped  superficially  by  a  
perimysium,  and  further  surrounded  by  an  epimysium  (28).  The  epimysium  and  
perimysium  are  composed  mainly  of  type  I  and  III  collagens,  which  most  likely  act  as  
molecular  springs  to  aid  in  protecting  muscle  fibers  from  stretch-­induced  injury  (1).    The  
endomysium  consists  of  type  I  and  III  collagens  that  form  honeycomb  like  structures  
around  muscle  fibers,  and  eventually  meet  to  form  the  tendon  (28).  The  collagens  within  
the  endomysium  are  important  for  the  transmission  of  forces  longitudinally  through  the  
muscle,  and  also  laterally  between  muscle  fibers  (45,  46).  The  propagation  of  lateral  
forces  is  accomplished  through  the  connection  of  the  endomysium  to  the  basement  
membranes  around  muscle  fibers,  composed  of  the  type  IV  and  VI  collagens  (28).  
Connecting  the  fibrillar  collagen-­rich  endomysium  to  the  network  collagen-­rich  
basement  membrane  is  accomplished  through  integrin,  fibronectin,  and  other  structural  
proteins.    
   Within  skeletal  muscle  cells,  the  basic  structural  component  responsible  for  force  
generation  is  the  sarcomere,  which  are  tightly  arranged  in  small,  parallel  myofibrils  to  
allow  the  muscle  fiber  to  contract.  Individual  sarcomeres  are  composed  of  three  main  
structures-­  the  thick  filament,  the  thin  filament,  and  the  Z-­disk  (52).  Thick  filaments  are  
comprised  of  myosin  heavy  chain,  the  main  molecular  driver  of  contraction,  which  binds  
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actin  on  thin  filaments  to  contract.  Thin  filaments  are  composed  of  actin  and  other  
regulatory  proteins,  and  are  anchored  to  the  Z-­disk  by  the  structural  proteins,  titin  and  
nebulin  (29,  52).  The  Z-­disks  are  responsible  for  the  proper  transmission  of  forces  
generated  both  longitudinally  and  laterally  through  connections  to  other  structures  within  
and  around  the  muscle  cell.  Longitudinal  forces  are  carried  from  the  Z-­disks  to  the  actin  
cytoskeleton  of  the  cell,  and  allow  forces  to  propagate  along  the  muscle  through  the  
tendon.  Lateral  forces  are  produced  by  linkages  from  the  Z-­disk  to  the  dystrophin-­
glycoprotein  complex  (DGC),  a  membrane-­bound  structure  that  is  attached  
extracellularly  to  laminin  and  fibronectin  (5,  39).  The  interaction  of  the  contracting  
sarcomere  through  the  Z-­disk  and  actin  cytoskeleton,  the  DGC,  and  the  ECM  allow  for  
the  proper  function  of  skeletal  muscles  to  transmit  forces,  reduce  contraction-­induced  
injury,  and  allow  for  proper  function  and  locomotion.    
There  are  three  main  types  of  contraction  in  skeletal  muscle,  each  relate  to  the  
change  in  length  of  the  fibers  during  contraction  of  the  muscle.  Isometric  contractions  
occur  when  the  muscle  is  contracting  in  the  absence  of  a  change  in  length,  indicating  
that  the  force  generated  by  the  muscle  is  equal  to  the  load  being  placed  on  it  (12).  The  
force  that  a  muscle  can  generate  is  highest  during  isometric  contraction,  and  this  is  
called  maximum  isometric  force  (Po).  Normalizing  Po  to  the  CSA  of  the  muscle  yields  
specific  maximum  tetanic  force  (sPo),  which  is  a  powerful  indicator  of  muscle  function  
(6).  Concentric,  or  shortening  contractions,  occur  when  the  force  produced  by  muscle  is  
greater  than  the  load,  and  a  decrease  in  length  occurs  in  the  muscle  (12).  Conversely,  
when  the  load  on  the  muscle  is  greater  than  the  force  being  produced,  a  lengthening  
contraction  occurs,  and  the  fibers  are  increasing  in  length  as  they  are  contracting.  
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Contraction-­induced  injury  occurs  during  lengthening  contractions,  where  the  frequency  
or  magnitude  of  the  force  disrupts  sarcomere  structure,  and  can  damage  the  muscle  
plasma  membrane,  called  the  sarcolemma  (12,  34).  Minor  contraction-­induced  injuries  
are  common  during  exercise  or  resistance  training  and  result  in  positive  adaptations  in  
muscle  protein  synthesis  and  over  time  can  yield  increases  in  Po  (11,  17).  A  summary  of  
the  signaling  pathways  that  regulate  both  muscle  protein  synthesis  and  degradation  is  
outlined  in  Figure  1.2.  
Perhaps  the  most  widely  studied  activator  of  protein  synthesis  and  muscle  
hypertrophy  is  IGF-­1.  There  are  alternative  spliced  isoforms  of  IGF-­1,  including  IGF-­
1Ea,  IGF-­1Eb,  and  Mechano  Growth  Factor  (MGF)  (18).  These  isoforms  appear  to  have  
various  roles  in  the  regulation  of  skeletal  muscle  growth.  Transgenic  mice  that  
overexpress  IGF-­1  under  the  control  of  muscle-­specific  promoters  have  increased  
muscle  mass,  CSA,  and  Po  compared  to  wild-­type  controls  (42).  IGF-­1  binds  to  its  
receptor  and  activates  insulin  receptor  substrate-­1,  IRS-­1,  which  then  directs  the  
activation  if  phosphatidylinositol-­3-­kinase  (PI3K),  and  downstream  results  in  Akt/mTOR  
signaling,  causing  muscle  protein  synthesis  (48).  mTOR  is  considered  one  of  the  most  
critical  intracellular  regulators  of  skeletal  muscle  mass.  While  IGF-­1  activates  mTOR  
through  Akt,  the  alternately  spliced,  locally  expressed  isoform  of  IGF-­1,  IGF-­1Ea,  
appears  to  activate  mTOR  independent  of  Akt.  Downstream,  mTOR  signals  through  the  
activation  of  p70S6K,  which  increases  protein  synthesis  by  activating  S6  and  eIF4B,  
factors  that  increase  mRNA  translation  and  ribosomal  biogenesis  (60).  Phosphorylation  
of  4EBP1  by  mTOR  releases  its  inhibition  on  eIF4E,  allowing  translation  to  proceed.  
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The  targeted  inhibition  of  mTOR  by  the  drug  rapamycin  is  an  effective  way  to  curb  
protein  synthesis  and  can  halt  load-­induced  muscle  growth  (44).    
More  severe  lengthening  contraction-­induced  injuries  can  cause  massive  amount  
of  sarcomere  damage  and  subsequent  proteolytic  remodeling  within  sarcomeres.  
Damage  to  the  sarcolemma  allows  an  influx  of  extracellular  Ca2+  into  the  fiber  and  
activates  of  an  important  protease,  m-­calpain  (24).  Once  active,  m-­calpain  degrades  
titin,  and  this  process  likely  assists  in  the  disassembly  of  damaged  myofibrils  and  
subsequent  physical  release  of  sarcomeric  proteins  so  that  they  can  be  broken  down  
fully.  Once  free  from  the  sarcomere,  damaged  actin,  myosin,  and  other  sarcomeric  
proteins  are  degraded  in  muscle  fibers  through  induction  of  the  E3  ubiquitin  ligases,  
atrogin-­1  and  MuRF-­1  (48).  These  ligases  direct  the  polyubiquination  of  damaged  
proteins,  and  targets  these  proteins  for  breakdown  in  the  26S  proteasome.  This  process  
likely  serves  as  a  method  to  recycle  dysfunctional  proteins  into  free  amino  acids  to  be  
used  for  subsequent  synthesis  of  new  proteins,  and  regeneration  of  the  damaged  
muscle  fiber.    
Repair  of  injured  muscle  fibers  is  also  facilitated  by  other  types  of  cells  within  
skeletal  muscle.  Outside  of  the  muscle  fibers,  the  other  main  cellular  components  of  
skeletal  muscle  are  satellite  cells  and  non-­myogenic  cells.  Satellite  cells  are  muscle  
stem  cells  that  typically  exist  in  a  quiescent  state  between  the  basement  membrane  and  
sarcolemma  of  the  muscle  fiber  (22).  Quiescence  in  satellite  cells  is  marked  by  the  
transcription  factor  Pax7,  which  is  required  for  the  specification  of  satellite  cells  to  the  
myogenic  lineage  (47).  Upon  activation,  satellite  cells  break  from  their  quiescent  niche,  
migrate  to  the  site  of  injury,  proliferate,  and  fuse  to  damaged  muscle  fibers  to  repair  
   10  
them.  The  process  of  going  from  a  quiescent  satellite  cell  to  a  differentiated  muscle  fiber  
is  a  complex  process  that  requires  the  activation  of  a  group  of  bHLH  transcription  
factors,  called  the  myogenic  regulatory  factors  (MRF)  (47).  The  MRFs  include  Myf5,  
MyoD,  myogenin,  and  MRF4,  and  each  directs  transcription  during  specific  stages  of  
skeletal  muscle  differentiation.  Satellite  cells  exhibit  asymmetrical  division,  where  one  
daughter  cell  retains  Pax7  expression  and  maintains  the  satellite  cell  pool  by  remaining  
a  quiescent  satellite  cell,  while  the  other  daughter  cell  becomes  a  myogenic  satellite  cell  
and  Pax7  directs  the  activation  of  Myf5.  The  myogenic  cell  then  continues  proliferating  
and  expresses  MyoD.  MyoD  is  further  upregulated  quickly  after  differentiation,  and  soon  
thereafter  myogenin  is  expressed.  The  induction  of  myogenin  expression  is  associated  
with  a  decrease  in  Myf5  and  MyoD  expression,  and  the  cell  withdraws  from  the  cell  
cycle.  As  the  cell  continues  to  differentiate,  myogenin  levels  fall  as  MRF4  levels  rise  
(47).    
As  a  differentiated  myogenic  cell  fuses  with  a  damaged  muscle  fiber,  it  adds  a  
nucleus  to  the  fiber.  Nuclei  to  healthy  fibers  are  located  on  the  periphery  of  the  cell,  but  
newly  added  nuclei  are  centrally  located  in  the  fiber  (22).  The  reason  behind  this  is  
unclear,  but  it  has  been  proposed  that  the  reason  for  a  centrally  located  nucleus  is  to  
offer  a  logistically  favorable  location  for  newly  synthesizing  sarcomeric  proteins  in  the  
muscle  fiber  (26).  Sarcomeric  proteins  are  very  large  and  would  require  substantial  
cellular  energy  to  package  them  in  a  golgi  apparatus,  so  they  are  often  synthesized  
directly  at  the  sarcomere  instead  of  an  endoplasmic  reticulum.  As  the  cell  is  repaired,  
the  nucleus  then  assumes  the  normal  peripheral  location.      
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Non-­myogenic  cells  also  contribute  to  the  maintenance  and  repair  of  muscle  
fibers.  Like  tendons,  muscles  contain  fibroblasts  that  regulate  and  maintain  the  ECM  
within  skeletal  muscle.  In  addition  to  their  capacity  to  synthesize  ECM,  fibroblasts  also  
play  an  important  role  in  the  direction  of  satellite  cell  activity.  After  skeletal  muscle  
injury,  muscle  fibroblasts  proliferate  in  response  to  injury  in  close  association  with  
satellite  cells  (41).  The  process  of  regeneration  for  muscle  fibers  takes  significantly  
longer  than  the  deposition  of  ECM,  so  the  coordination  of  timing  between  satellite  cells  
and  fibroblasts  is  critical  for  the  proper  regeneration  of  skeletal  muscle.  After  
proliferating,  fibroblasts  synthesize  matrix  as  a  scaffold  for  regenerating  muscle  fibers,  
and  allow  satellite  cells  to  differentiate  and  participate  in  fusion  to  damaged  fibers.  
Without  fibroblasts,  satellite  cells  will  prematurely  differentiate,  and  this  results  in  
smaller  muscle  fibers  and  impaired  regeneration.  In  the  absence  of  satellite  cells,  the  
muscle  does  not  regenerate  at  all  and  exhibits  extreme  levels  of  ECM  deposition,  which  
completely  disrupts  normal  muscle  architecture  due  to  the  replacement  of  muscle  area  
with  fibrosis,  or  scar  tissue.    
SKELETAL  MUSCLE  LIPID  METABOLISM  
   Skeletal  muscle  uses  a  variety  of  fuel  sources  for  generation  of  cellular  energy  in  
the  form  of  ATP.  There  are  three  main  cellular  pathways  to  generate  ATP.  Anaerobic  
ATP  generation  can  result  from  the  hydrolysis  of  phosphocreatine  via  creatine  kinase,  
or  by  anaerobic  glycolysis  (30).  ATP  is  also  generated  in  mitochondria  through  oxidative  
phosphorylation.  Aerobic  ATP  generation  in  mitochondria  can  utilize  byproducts  from  
either  glycolysis  or  lipids,  but  the  pathways  to  metabolize  lipids  will  be  focused  on  here.    
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   Lipids  are  transported  through  the  blood  in  triglyceride-­rich  spheres  called  
chylomicrons.  For  lipids  to  enter  muscle  cells,  free  fatty  acids  must  be  cleaved  from  
triglyceride  molecules  by  lipoprotein  lipase  (50),  which  enables  long-­chain  free  fatty  
acids  to  enter  the  cell  via  the  CD36  lipid  transporter  (23).  Once  inside  the  cell,  fatty  
acids  stimulate  the  activation  of  the  peroxisome  proliferator-­activated  receptors  
(PPARs),  which  direct  the  expression  of  genes  related  to  lipogenesis,  lipid  storage,  and  
metabolic  homeostasis  (2).  There  are  three  PPAR  isoforms:  PPARα,  PPARδ,  and  
PPARγ,  and  all  are  expressed  in  skeletal  muscle,  though  PPARδ  is  the  most  highly  
expressed  in  this  tissue.  Fatty  acids  inside  the  cell  can  either  be  processed  for  storage  
in  triglyceride  rich  droplets,  or  be  utilized  for  energy  production  in  mitochondria.  Storage  
of  lipid  requires  the  activation  of  several  regulatory  enzymes  that  esterify  fatty  acids  with  
glycerol-­3-­phosphate,  which  is  also  a  component  of  glycolysis  (56).  Two  of  the  most  
important  proteins  to  catalyze  the  formation  of  triglycerides  from  free  fatty  acids  are  
glycerol-­3-­phosphate  acyltransferease  (GPAT),  which  directs  the  committed  step  in  
formation  of  triglyceride,  and  diacylglycerol  acyltransferase  (DGAT),  which  catalyzes  the  
final  step  in  the  pathway,  resulting  in  the  formation  of  triglyceride.    
   Triglyceride-­rich  droplets  are  located  within  the  muscle  near  mitochondria,  and  
free  fatty  acids  are  cleaved  from  these  droplets  for  utilization  by  a  few  key  intracellular  
lipases,  hormone  sensitive  lipase  (HSL)  and  adipose  triglyceride  lipase  (ATGL)  (10,  56).  
Cleaved  free  fatty  acids  from  lipid  droplets,  or  fatty  acids  that  have  been  imported  in  the  
cell  through  CD36  can  then  be  utilized  in  mitochondria  after  first  linking  to  coenzyme  A,  
forming  a  fatty  acyl-­CoA  (23).  Fatty  acyl-­CoAs  cannot  enter  the  mitochondria  on  their  
own  due  to  their  polarity,  so  they  are  converted  into  neutral  acyl-­carnitine,  by  carnitine  
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palmitoyl  transferase-­I  (CPTI).  Acyl  carnitine  is  shuttled  inside  the  mitochondria  by  
carnitine  acyl-­carnitine  translocase  (CAT),  and  in  order  to  be  oxidized  in  the  
mitochondria,  must  again  be  converted  to  a  fatty  acyl-­CoA,  this  time  by  CPTII.  After  
several  rounds  of  beta-­oxidation  within  mitochondria,  long-­chain  acyl-­CoAs  are  broken  
down  into  many  two-­carbon  acetyl-­CoA  molecules,  and  can  then  be  utilized  for  ATP  
production  in  the  citric  acid  cycle,  and  electron  transport  chain.    
   In  cases  of  lipid  excess,  a  third  fate  of  fatty  acids  can  result  in  deleterious  effects  
on  skeletal  muscle  homeostasis.  Over  accumulation  of  lipid  within  cells  increases  the  
abundance  of  lipid  intermediates,  such  as  diglyceride  and  ceramide,  which  can  activate  
inflammatory  pathways  such  as  c-­Jun  NH2-­terminal  kinase  (JNK)  and  IκB  kinase-­beta  
(IKKβ)  (56),  and  decrease  insulin  signaling.  Increased  intracellular  lipid  intermediates  
leads  to  the  phosphorylation  IRS-­1  at  multiple  serine  residues,  which  inhibits  IRS-­1  
tyrosine  phosphorylation,  necessary  for  insulin  stimulated  glucose  uptake  (58).  IRS-­1  
serine  phosphorylation  is  thought  to  be  performed  by  a  member  of  the  novel  family  of  
protein  kinase  Cs,  PKCθ  (20).  It  is  not  clear  whether  DAG  activates  PKCθ  directly  or  
through  the  activation  of  JNK  and  IKKβ  (56).  This  pathway  is  considered  to  explain  the  
link  between  insulin  resistance  and  obesity,  where  excess  lipid  drastically  reduces  
insulin  signaling.  The  insulin  pathway  shares  many  of  the  same  cellular  kinases  and  
proteins  as  the  IGF-­1  pathway,  though  it  is  unknown  what  effect  excess  lipid  has  on  
IGF-­1  signaling.  However,  the  JNK  and  IKKβ  pathways  leads  to  the  activation  of  the  
transcription  factor,  NFκB,  which  is  a  major  cellular  mediator  of  inflammation  and  
muscle  atrophy  through  the  induction  of  the  E3  ubiquitin  ligase,  MuRF-­1  (48).  
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   Excess  extracellular  lipid  can  also  have  detrimental  effects  on  muscle  function.  
Large  lipid  droplets  can  be  mediators  of  inflammation  in  disease  through  the  synthesis  
of  pro-­inflammatory  eicosanoids  (4,  57).  This  occurs  via  the  production  of  arachidonyl  
lipids  within  droplets,  as  the  enzymes  for  arachidonic  acid  synthesis  localize  to  lipid  
droplets.  Arachidonic  acid  is  then  converted  to  eicosanoids  though  eicosanoid  forming  
enzymes,  also  located  on  lipid  droplets.  Eicosanoids  such  as  prostaglandins  and  
leukotrienes  have  a  wide  array  of  cellular  functions,  but  many  have  potent  pro-­
inflammatory  effects  (4)  and  can  be  detrimental  to  the  differentiation  of  skeletal  muscle  
progenitor  cells  (36).    
RATIONALE  AND  APPROACH  
     Improving  the  treatment  of  rotator  cuff  tears  requires  the  proper  understanding  of  
the  cellular  and  molecular  changes  that  occur  within  rotator  cuff  tendons  and  muscles.  
As  the  pathways  that  govern  tendon  adaptation  are  largely  unknown,  studies  that  
identify  transcriptional  and  cellular  regulators  of  tendon  growth  and  adaptation  will  
provide  much  needed  information  to  enhance  tendon  regeneration  after  rotator  cuff  
surgery.  Conversely,  mechanisms  of  muscle  atrophy,  growth,  and  regeneration  
following  injury  has  been  widely  studied  in  the  literature,  but  there  is  still  a  lack  of  
information  as  to  why  the  rotator  cuff  muscle  develops  myosteatosis.  Understanding  the  
effect  of  muscle  lipid  accumulation  on  muscle  function  will  enable  the  development  of  
strategies  to  augment  muscle  regeneration  following  these  injuries.      
The  purpose  of  this  dissertation  is  to  identify  several  unknowns  about  tendon  
biology,  scleraxis  function,  and  myosteatosis.  For  studies  in  tendon,  the  main  questions  
addressed  in  this  dissertation  include  i)  which  populations  of  fibroblasts  can  participate  
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in  the  growth  and  adaptation  of  adult  tendon,  ii)  whether  scleraxis  is  required  for  tendon  
adaptation  and  growth  in  adulthood,  and  iii)  whether  scleraxis  may  play  a  central  role  in  
the  differentiation  of  tendon  progenitor  cells.  These  questions  will  be  addressed  in  
Chapter  II  and  III,  using  a  combination  of  transgenic  mouse  models,  gene  expression,  
and  a  novel  model  of  tendon  growth  and  adaptation.  For  studies  in  myosteatosis,  the  
main  research  questions  that  are  addressed  here  are  i)  the  identification  of  molecular  
pathways  that  can  explain  the  increase  in  lipid  following  rotator  cuff  tear,  and  ii)  
measurement  of  the  functional  consequences  of  increased  intra-­  and  intermyocellular  
lipid  to  skeletal  muscle.  These  questions  will  be  addressed  in  Chapter  IV,  using  a  
variety  of  omics  platforms,  large  scale  bioinformatics,  muscle  force  measurement,  and  
mitochondrial  activity  assays  in  a  rat  model.  In  total,  the  findings  of  these  studies  will  
add  to  the  growing  literature  on  tendon  and  muscle  physiology,  and  hopefully  lead  to  
new  treatment  directions  for  patients  with  muscle  and  tendon  injuries.    
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Figure  1.1.  Overview  of  pathological  changes  to  muscle  during  rotator  cuff  tear.  The  
intact  rotator  cuff  in  posterior  view  is  shown  on  the  left,  with  the  supraspinatus  and  
infraspinatus  visible  (not  shown  are  the  teres  minor  and  subscapularis).  Following  
chronic  rotator  cuff  tear,  shown  here  for  the  supraspinatus,  the  tendon  retracts,  and  
the  rotator  cuff  muscle  undergoes  dramatic  atrophy,  fibrosis,  and  lipid  infiltration,  
collectively  referred  to  as  myosteatosis.      
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Figure  1.2.  Overview  of  intracellular  pathways  within  muscle  that  contribute  to  protein  
synthesis  or  protein  breakdown.  From  Gumucio  and  Mendias,  2013(21)  
  
  
     
   18  
REFERENCES  
1.   Arruda  EM,  Mundy  K,  Calve  S,  Baar  K.  Denervation  does  not  change  the  ratio  
of  collagen  I  and  collagen  III  mRNA  in  the  extracellular  matrix  of  muscle.  Am  J  
Physiol  Regul  Integr  Comp  Physiol  292:  R983–R987,  2007.  
2.   Barish  GD,  Narkar  VA,  Evans  RM.  PPAR  delta:  a  dagger  in  the  heart  of  the  
metabolic  syndrome.  J  Clin  Invest  116:  590–597,  2006.  
3.   Bedi  A,  Dines  J,  Warren  RF,  Dines  DM.  Massive  tears  of  the  rotator  cuff.  The  
Journal  of  Bone  and  Joint  Surgery  92:  1894–1908,  2010.  
4.   Bozza  PT,  Viola  JPB.  Lipid  droplets  in  inflammation  and  cancer.  Prostaglandins  
Leukot  Essent  Fatty  Acids  82:  243–250,  2010.  
5.   Capetanaki  Y,  Bloch  RJ,  Kouloumenta  A,  Mavroidis  M,  Psarras  S.  Muscle  
intermediate  filaments  and  their  links  to  membranes  and  membranous  organelles.  
Experimental  Cell  Research  313:  2063–2076,  2007.  
6.   Claflin  DR,  Larkin  LM,  Cederna  PS,  Horowitz  JF,  Alexander  NB,  Cole  NM,  
Galecki  AT,  Chen  S,  Nyquist  LV,  Carlson  BM,  Faulkner  JA,  Ashton-­Miller  JA.  
Effects  of  high-­  and  low-­velocity  resistance  training  on  the  contractile  properties  of  
skeletal  muscle  fibers  from  young  and  older  humans.  J  Appl  Physiol  111:  1021–
1030,  2011.  
7.   Colvin  AC,  Egorova  N,  Harrison  AK,  Moskowitz  A,  Flatow  EL.  National  trends  
in  rotator  cuff  repair.  The  Journal  of  Bone  and  Joint  Surgery  94:  227–233,  2012.  
8.   Cserjesi  P,  Brown  D,  Ligon  KL,  Lyons  GE,  Copeland  NG,  Gilbert  DJ,  Jenkins  
NA,  Olson  EN.  Scleraxis:  a  basic  helix-­loop-­helix  protein  that  prefigures  skeletal  
formation  during  mouse  embryogenesis.  Development  121:  1099–1110,  1995.  
9.   Docheva  D,  Hunziker  EB,  Fässler  R,  Brandau  O.  Tenomodulin  is  necessary  for  
tenocyte  proliferation  and  tendon  maturation.  Mol  Cell  Biol  25:  699–705,  2005.  
10.   Ducharme  NA,  Bickel  PE.  Lipid  droplets  in  lipogenesis  and  lipolysis.  
Endocrinology  149:  942–949,  2008.  
11.   Evans  WJ.  Protein  Nutrition  and  Resistance  Exercise.  Can  J  Appl  Physiol  26:  
S141–S152,  2001.  
12.   Faulkner  JA,  Brooks  SV,  Opiteck  JA.  Injury  to  Skeletal  Muscle  Fibers  During  
Contractions:  Conditions  of  Occurrence  and  Prevention.  Physical  Therapy  73:  
911–921,  1993.  
13.   Gayraud-­Morel  B,  Chrétien  F,  Tajbakhsh  S.  Skeletal  muscle  as  a  paradigm  for  
regenerative  biology  and  medicine.  http://dxdoiorg/102217/1746075142293  4:  
293–319,  2009.  
   19  
14.   Gerber  C,  Schneeberger  AG,  Hoppeler  H,  Meyer  DC.  Correlation  of  atrophy  
and  fatty  infiltration  on  strength  and  integrity  of  rotator  cuff  repairs:  a  study  in  
thirteen  patients.  J  Shoulder  Elbow  Surg  16:  691–696,  2007.  
15.   Gerber  C,  Wirth  SH,  Farshad  M.  Treatment  options  for  massive  rotator  cuff  
tears.  J  Shoulder  Elbow  Surg  20:  S20–9,  2011.  
16.   Gladstone  JN,  Bishop  JY,  Lo  IKY,  Flatow  EL.  Fatty  infiltration  and  atrophy  of  
the  rotator  cuff  do  not  improve  after  rotator  cuff  repair  and  correlate  with  poor  
functional  outcome.  American  Journal  of  Sports  Medicine  35:  719–728,  2007.  
17.   Glass  DJ.  Molecular  mechanisms  modulating  muscle  mass.  Trends  in  Molecular  
Medicine  9:  344–350,  2003.  
18.   Goldspink  G.  Mechanical  signals,  IGF-­I  gene  splicing,  and  muscle  adaptation.  
Physiology  (Bethesda)  20:  232–238,  2005.  
19.   Goutallier  D,  Postel  JM,  Bernageau  J,  Lavau  L,  Voisin  MC.  Fatty  muscle  
degeneration  in  cuff  ruptures.  Pre-­  and  postoperative  evaluation  by  CT  scan.  Clin  
Orthop  Relat  Res  :  78–83,  1994.  
20.   Griffin  ME,  Marcucci  MJ,  Cline  GW,  Bell  K,  Barucci  N,  Lee  D,  Goodyear  LJ,  
Kraegen  EW,  White  MF,  Shulman  GI.  Free  fatty  acid-­induced  insulin  resistance  
is  associated  with  activation  of  protein  kinase  C  theta  and  alterations  in  the  insulin  
signaling  cascade.  Diabetes  48:  1270–1274,  1999.  
21.   Gumucio  JP,  Mendias  CL.  Atrogin-­1,  MuRF-­1,  and  sarcopenia.  Endocrine  43:  
12–21,  2013.  
22.   Hawke  TJ,  Garry  DJ.  Myogenic  satellite  cells:  physiology  to  molecular  biology.  J  
Appl  Physiol  91:  534–551,  2001.  
23.   Holloway  GP,  Luiken  JJFP,  Glatz  JFC,  Spriet  LL,  Bonen  A.  Contribution  of  
FAT/CD36  to  the  regulation  of  skeletal  muscle  fatty  acid  oxidation:  an  overview.  
Acta  Physiologica  194:  293–309,  2008.  
24.   Jackman  RW,  Kandarian  SC.  The  molecular  basis  of  skeletal  muscle  atrophy.  
Am  J  Physiol,  Cell  Physiol  287:  C834–43,  2004.  
25.   Jain  NB,  Wilcox  RB,  Katz  JN,  Higgins  LD.  Clinical  examination  of  the  rotator  
cuff.  PM  R  5:  45–56,  2013.  
26.   Kiri  A,  Goldspink  G.  RNA–protein  interactions  of  the  3′  untranslated  regions  of  
myosin  heavy  chain  transcripts.  J  Muscle  Res  Cell  Motil  23:  119–129,  2002.  
27.   Kjaer  M,  Langberg  H,  Heinemeier  K,  Bayer  ML,  Hansen  M,  Holm  L,  Doessing  
S,  Kongsgaard  M,  Krogsgaard  MR,  Magnusson  SP.  From  mechanical  loading  
to  collagen  synthesis,  structural  changes  and  function  in  human  tendon.  Scand  J  
   20  
Med  Sci  Sports  19:  500–510,  2009.  
28.   Kjaer  M.  Role  of  extracellular  matrix  in  adaptation  of  tendon  and  skeletal  muscle  
to  mechanical  loading.  Physiol  Rev  84:  649–698,  2004.  
29.   Knupp  C,  Luther  PK,  Squire  JM.  Titin  Organisation  and  the  3D  Architecture  of  
the  Vertebrate-­striated  Muscle  I-­band.  Journal  of  Molecular  Biology  322:  731–739,  
2002.  
30.   Lanza  IR,  Befroy  DE,  Kent-­Braun  JA.  Age-­related  changes  in  ATP-­producing  
pathways  in  human  skeletal  muscle  in  vivo.  J  Appl  Physiol  99:  1736–1744,  2005.  
31.   Léjard  V,  Brideau  G,  Blais  F,  Salingcarnboriboon  R,  Wagner  G,  Roehrl  MHA,  
Noda  M,  Duprez  D,  Houillier  P,  Rossert  J.  Scleraxis  and  NFATc  Regulate  the  
Expression  of  the  Pro-­α1(I)  Collagen  Gene  in  Tendon  Fibroblasts.  Journal  of  
Biological  Chemistry  282:  17665–17675,  2007.  
32.   Lin  J,  Weintraub  N,  Aragaki  D.  Nonsurgical  Treatment  for  Rotator  Cuff  Injury  in  
the  Elderly.  Journal  of  the  American  Medical  Directors  Association  9:  626–632,  
2008.  
33.   Magnusson  SP,  Hansen  P,  Kjaer  M.  Tendon  properties  in  relation  to  muscular  
activity  and  physical  training.  Scand  J  Med  Sci  Sports  13:  211–223,  2003.  
34.   McCully  KK,  Faulkner  JA.  Injury  to  skeletal  muscle  fibers  of  mice  following  
lengthening  contractions.  J  Appl  Physiol  59:  119–126,  1985.  
35.   Mendias  CL,  Gumucio  JP,  Bakhurin  KI,  Lynch  EB,  Brooks  SV.  Physiological  
loading  of  tendons  induces  scleraxis  expression  in  epitenon  fibroblasts.  J  Orthop  
Res  30:  606–612,  2012.  
36.   Mendias  CL,  Tatsumi  R,  Allen  RE.  Role  of  cyclooxygenase-­1  and  -­2  in  satellite  
cell  proliferation,  differentiation,  and  fusion.  Muscle  Nerve  30:  497–500,  2004.  
37.   Meryon  E.  On  Granular  and  Fatty  Degeneration  of  the  Voluntary  Muscles.  Med  
Chir  Trans  35:  73–84.1,  1852.  
38.   Michna  H,  Hartmann  G.  Adaptation  of  tendon  collagen  to  exercise.  International  
Orthopaedics  (SICOT)  13:  161–165,  1989.  
39.   Monti  RJ,  Roy  RR,  Hodgson  JA,  Edgerton  VR.  Transmission  of  forces  within  
mammalian  skeletal  muscles.  J  Biomech  32:  371–380,  1999.  
40.   Murchison  ND,  Price  BA,  Conner  DA,  Keene  DR,  Olson  EN,  Tabin  CJ,  
Schweitzer  R.  Regulation  of  tendon  differentiation  by  scleraxis  distinguishes  
force-­transmitting  tendons  from  muscle-­anchoring  tendons.  Development  134:  
2697–2708,  2007.  
   21  
41.   Murphy  MM,  Lawson  JA,  Mathew  SJ,  Hutcheson  DA,  Kardon  G.  Satellite  
cells,  connective  tissue  fibroblasts  and  their  interactions  are  crucial  for  muscle  
regeneration.  Development  138:  3625–3637,  2011.  
42.   Musaro  A,  McCullagh  K,  Paul  A,  Houghton  L,  Dobrowolny  G,  Molinaro  M,  
Barton  ER,  Sweeney  HL,  Rosenthal  N.  Localized  Igf-­1  transgene  expression  
sustains  hypertrophy  and  regeneration  in  senescent  skeletal  muscle.  Nat  Genet  
27:  195–200,  2001.  
43.   Nho  SJ,  Yadav  H,  Shindle  MK,  MacGillivray  JD.  Rotator  Cuff  Degeneration:  
Etiology  and  Pathogenesis.  American  Journal  of  Sports  Medicine  36:  987–993,  
2008.  
44.   Pallafacchina  G,  Calabria  E,  Serrano  AL,  Kalhovde  JM,  Schiaffino  S.  A  
protein  kinase  B-­dependent  and  rapamycin-­sensitive  pathway  controls  skeletal  
muscle  growth  but  not  fiber  type  specification.  Proc  Natl  Acad  Sci  USA  99:  9213,  
2002.  
45.   Purslow  PP,  Trotter  JA.  The  morphology  and  mechanical  properties  of  
endomysium  in  series-­fibred  muscles:  variations  with  muscle  length.  J  Muscle  
Res  Cell  Motil  15:  299–308,  1994.  
46.   Purslow  PP.  Muscle  fascia  and  force  transmission.  J  Bodyw  Mov  Ther  14:  411–
417,  2010.  
47.   Rudnicki  MA,  Le  Grand  F,  McKinnell  I,  Kuang  S.  The  Molecular  Regulation  of  
Muscle  Stem  Cell  Function.  Cold  Spring  Harb  Symp  Quant  Biol  73:  323–331,  
2008.  
48.   Sandri  M.  Signaling  in  muscle  atrophy  and  hypertrophy.  Physiology  (Bethesda)  
23:  160–170,  2008.  
49.   Schweitzer  R,  Chyung  JH,  Murtaugh  LC,  Brent  AE,  Rosen  V,  Olson  EN,  
Lassar  A,  Tabin  CJ.  Analysis  of  the  tendon  cell  fate  using  Scleraxis,  a  specific  
marker  for  tendons  and  ligaments.  Development  128:  3855–3866,  2001.  
50.   Seip  RL,  Semenkovich  CF.  Skeletal  muscle  lipoprotein  lipase:  molecular  
regulation  and  physiological  effects  in  relation  to  exercise.  Exerc  Sport  Sci  Rev  
26:  191–218,  1998.  
51.   Shukunami  C,  Takimoto  A,  Oro  M,  Hiraki  Y.  Scleraxis  positively  regulates  the  
expression  of  tenomodulin,  a  differentiation  marker  of  tenocytes.  Dev  Biol  298:  
234–247,  2006.  
52.   Squire  JM.  Architecture  and  function  in  the  muscle  sarcomere.  Current  Opinion  in  
Structural  Biology  7:  247–257,  1997.  
53.   United  States  Bone  and  Joint  Initiative:  The  Burden  of  Musculoskeletal  
   22  
Diseases  in  the  United  States  (BMUS),  Second  Edition,  2011.  Rosemont,  IL  
54.   Walsworth  MK,  Doukas  WC,  Murphy  KP,  Bimson  W,  Mielcarek  BJ,  Michener  
LA.  Descriptive  analysis  of  patients  undergoing  shoulder  surgery  at  a  tertiary  care  
military  medical  center.  Mil  Med  174:  642–644,  2009.  
55.   Wang  JH-­C.  Mechanobiology  of  tendon.  J  Biomech  39:  1563–1582,  2006.  
56.   Watt  MJ.  Storing  up  trouble:  does  accumulation  of  intramyocellular  triglyceride  
protect  skeletal  muscle  from  insulin  resistance?  Clin  Exp  Pharmacol  Physiol  36:  
5–11,  2009.  
57.   Yaqoob  P.  Fatty  acids  as  gatekeepers  of  immune  cell  regulation.  Trends  Immunol  
24:  639–645,  2003.  
58.   Yu  C,  Chen  Y,  Cline  GW,  Zhang  D,  Zong  H,  Wang  Y,  Bergeron  R,  Kim  JK,  
Cushman  SW,  Cooney  GJ,  Atcheson  B,  White  MF,  Kraegen  EW,  Shulman  GI.  
Mechanism  by  which  fatty  acids  inhibit  insulin  activation  of  insulin  receptor  
substrate-­1  (IRS-­1)-­associated  phosphatidylinositol  3-­kinase  activity  in  muscle.  
Journal  of  Biological  Chemistry  277:  50230–50236,  2002.  
59.   Zhang  J,  Wang  JH-­C.  Mechanobiological  response  of  tendon  stem  cells:  
implications  of  tendon  homeostasis  and  pathogenesis  of  tendinopathy.  J  Orthop  
Res  28:  639–643,  2010.  
60.   Zoncu  R,  Efeyan  A,  Sabatini  DM.  mTOR:  from  growth  signal  integration  to  
cancer,  diabetes  and  ageing.  Nat  Rev  Mol  Cell  Biol  12:  21–35,  2010.  
  












Mechanical  loading  can  increase  tendon  cross-­sectional  area  (CSA),  but  the  
mechanisms  by  which  this  occurs  are  largely  unknown.  To  gain  a  greater  understanding  
of  the  cellular  mechanisms  of  adult  tendon  growth  in  response  to  mechanical  loading,  
we  used  a  synergist  ablation  model  whereby  a  tenectomy  of  the  Achilles  tendon  was  
performed  to  induce  growth  of  the  synergist  plantaris  tendon.  We  hypothesized  that,  
following  synergist  ablation,  progenitor  cells  in  the  epitenon  would  proliferate  and  
increase  the  size  of  the  existing  tendon  matrix.  Adult  male  mice  were  subjected  to  a  
bilateral  Achilles  tenectomy,  and  plantaris  tendons  were  isolated  from  mice  at  0,  2,  7,  
14,  and  28  days  after  surgery.  Tendons  were  sectioned  stained  with  either  fast  green  
and  hematoxylin,  prepared  for  fluorescent  microscopy,  or  prepared  for  gene  expression  
of  scleraxis  and  type  I  collagen.  Following  overload,  there  was  a  dramatic  increase  in  
total  CSA  of  tendons,  while  the  size  of  the  original  tendon  matrix  was  not  changed.  
Growth  primarily  occurred  through  the  formation  of  a  neotendon  matrix  between  the  
original  tendon  and  the  epitenon,  and  contained  cells  that  were  proliferative  and  
scleraxis  positive.  Additionally,  an  initial  expansion  of  fibroblast  cells  occurred  prior  to  
the  synthesis  of  new  extracellular  matrix.  Fibroblasts  in  the  original  tendon  did  not  re-­
enter  the  cell  cycle.  The  results  from  this  study  provide  new  insight  into  the  mechanisms  
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of  tendon  growth,  indicate  tendon  consists  mostly  of  post-­mitotic  cells,  and  that  growth  
of  tendon  primarily  occurs  from  the  most  superficial  layers  outward.    
INTRODUCTION  
Tendons  are  organized  into  functional  cable  like  units  of  primarily  type  I  collagen  
and  a  surrounding  matrix  of  network  collagens,  elastin,  and  various  proteoglycans  (2).  
Collagen  fibers  are  arranged  into  fascicles  in  hierarchical  order,  which  make  up  the  
tendon  proper.  Surrounding  this  is  a  basement  membrane  called  the  epitenon,  and  
loose  peritendinous  connective  tissue,  which  contains  the  principal  blood  and  nerve  
supply  to  the  tendon.  In  sedentary  mice,  tendons  continue  to  grow  in  size  and  length  
until  approximately  10  weeks  of  age  (15),  and  for  humans  the  majority  of  tendon  growth  
occurs  in  the  first  two  decades  of  life  (5).  Mechanical  loading  can  be  a  stimulus  for  
tendon  growth  after  adolescence,  with  vigorous  exercise  programs  resulting  in  
increases  in  cross-­sectional  area  (CSA)  of  approximately  30%  in  both  mice  (13)  and  
humans  (19).    
While  the  phenomenon  of  gross  tendon  growth  in  adult  animals  has  been  
reported,  the  cellular  mechanisms  that  are  responsible  for  this  growth  remain  largely  
unknown.  There  is,  however,  much  more  known  about  the  initial  formation  and  growth  
of  tendons  during  embryonic  development  and  early  post-­natal  stages  of  life.  Scleraxis  
is  a  basic  helix-­loop-­helix  transcription  factor  required  for  the  formation  of  limb  tendons  
in  embryonic  development,  with  genetic  inactivation  of  scleraxis  resulting  in  a  severe  
disruption  in  tendon  formation  (16).  Scleraxis  is  highly  regulated  by  both  mechanical  
loading,  and  also  the  TGF-­b/BMP  superfamily  (10,  14).  Mice  with  a  genetic  inactivation  
of  TGF-­b  signaling  (Tgfbr2-­/-­)  fail  to  form  limb  tendons  and  have  severely  disrupted  
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scleraxis  expression  (18),  and  administration  of  TGF-­b  to  cultured  tendon  fibroblasts  
results  in  increases  scleraxis  expression  (10,  14).  In  Achilles  tendons,  scleraxis  is  
expressed  in  the  majority  of  fibroblasts  throughout  the  tendon  up  through  2  months  of  
age,  but  past  this  point,  scleraxis  expression  is  confined  to  the  epitenon  region  (13).  
While  chronic  mechanical  loading  can  increase  tendon  mass,  CSA  and  fibroblast  
density  (13),  it  is  not  known  whether  the  increase  in  CSA  and  fibroblast  density  occurs  
due  to  proliferation  and  expansion  of  existing  tendon  fibroblast  cells  throughout  the  
tendon,  or  whether  growth  occurs  in  distinct  regions  within  the  tendon.    
To  gain  a  greater  understanding  into  the  mechanism  by  which  adult  tendon  
adapts  to  mechanical  loading,  and  the  role  of  scleraxis  in  adult  tendon  adaptation,  we  
subjected  adult  mice  to  bilateral  synergist  ablation  surgery.  By  removing  the  Achilles  
tendon,  the  synergist  plantaris  tendon  receives  a  robust,  supraphysiological  increase  in  
load  and  is  solely  responsible  for  all  plantarflexion  in  the  hindlimb  (1,  11).  We  
hypothesized  that,  following  synergist  ablation,  progenitor  cells  in  the  epitenon  would  
proliferate  and  increase  the  size  of  the  existing  tendon  matrix.  Additionally,  we  
hypothesized  that  synergist  ablation  would  increase  scleraxis  expression  throughout  the  
period  of  rapid  cell  expansion,  and  precede  the  synthesis  of  type  I  collagen.  
METHODS  
Animals.  All  experiments  were  approved  by  the  University  of  Michigan  
Committee  on  the  Use  and  Care  of  Animals,  and  all  procedures  followed  the  ethical  
guidelines  of  the  US  Public  Health  Service  and  American  Physiological  Society.  
Approximately  six  month  old  male  mice  that  express  green  fluorescent  protein  (GFP)  
under  the  control  of  the  scleraxis  promoter  (ScxGFP  mice,  N=6  per  group),  kindly  
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provided  by  Dr.  Ronen  Schweitzer  (17),  were  used  in  this  study.  To  induce  a  
supraphysiological  load  on  plantaris  tendons,  mice  were  anesthetized  with  isoflurane,  
and  bilateral  Achilles  tenectomies  were  performed  as  previously  described  (1).  A  
representative  image  of  this  surgical  procedure  is  displayed  in  Figure  2.1.  After  
tenectomy,  mice  were  allowed  to  recover  and  ambulate  freely  about  their  cages,  with  no  
post-­operative  analgesia  given.  At  2,  7,  14  or  28  days  after  the  surgery,  plantaris  
tendons  were  harvested  from  both  limbs.  Age-­matched  mice  that  did  not  undergo  
surgery  were  used  as  controls.  We  chose  these  time  points  based  on  previous  studies  
using  the  synergist  ablation  model  (1).  At  24  and  48  hours  prior  to  harvest,  mice  
received  an  intraperitoneal  injection  of  100µg  of  the  thymidine  analog  5-­ethynyl-­2’-­
deoxyuridine  (EdU,  Invitrogen)  to  mark  proliferative  cells.  At  the  time  of  harvest,  animals  
were  anesthetized  with  sodium  pentobarbital,  and  plantaris  tendons  were  removed.  The  
right  tendon  was  then  prepared  for  histology  while  RNA  was  isolated  from  the  left  
tendon.  Animals  were  then  humanely  euthanized  with  overdose  of  sodium  
pentobarbital.    
   Histology.  Plantaris  tendons  were  placed  in  TissueTek  (Sakura)  and  snap  frozen  
in  isopentane  cooled  in  liquid  nitrogen,  and  stored  at  -­80ºC  until  use.  Tendons  were  
sectioned  at  a  thickness  of  10  µm  on  a  cryostat,  and  either  stained  with  fast  green  and  
hematoxylin,  or  treated  with  DAPI  (Sigma  Aldrich)  and  a  Click-­iT  kit  with  AlexaFluor  546  
Azide  (Invitrogen)  to  label  EdU.  Slides  were  imaged  using  a  Axiovert  200M  microscope  
(Zeiss)  outfitted  with  the  ApoTome  system  and  an  8MP  digital  camera.  Total  CSA  was  
measured  by  pixel  area  in  imaged  fast  green  and  hematoxylin  sections,  and  converted  
to  square  microns  using  a  known  scale.  The  original  tendon  CSA  in  treated  samples  
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and  subtracted  from  the  total  tendon  area  to  obtain  neotendon  CSA.  Fibroblast  density  
for  each  region  of  the  tendon  was  calculated  by  dividing  the  number  of  nuclei  within  a  
specific  tendon  area  by  the  CSA.  All  histomorphometric  analyses  were  performed  in  
ImageJ  (NIH).    
Gene  expression.  Tendons  were  finely  minced  and  homogenized  in  QIAzol  
(Qiagen),  and  RNA  was  extracted  using  a  miRNeasy  Mini  kit  (Qiagen).  Total  RNA  was  
quantified  using  a  NanoDrop  (ThermoFisher),  and  RNA  was  reversed  transcribed  with  
an  iScript  cDNA  synthesis  kit  (Bio-­Rad).  Quantitative  PCR  was  performed  using  
SsoFast  EvaGreen  reagents  (Bio-­Rad)  in  a  CFX96  real  time  thermal  cycler  (Bio-­Rad),  
and  primers  to  detect  scleraxis  (SCX)  and  type  1a2  collagen  (COL1A2),  and  normalized  
to  the  stable  housekeeping  gene,  b2-­microglobulin  (B2M).  Primer  sequences  and  
cycling  parameters  have  been  previously  described  (3).  Differences  in  gene  expression  
between  time  points  were  quantified  using  the  2-­∆Ct  method  (20).    
Statistical  Analyses.    One-­way  ANOVAs  (a=0.05),  followed  by  Holm-­Sidak  post-­
hoc  sorting,  were  used  to  assess  differences  between  time  points.  Analysis  was  
performed  using  Prism  6.0  (GraphPad).  Values  are  presented  as  mean±SE.  
RESULTS  
Supraphysiological  overload  of  the  plantaris  tendon  resulted  in  the  generation  of  
an  immature  tendon  matrix,  or  neotendon,  between  the  epitenon  and  the  original  tendon  
matrix  (Figure  2.2).    The  initial  formation  of  the  neotendon  matrix  could  be  seen  as  early  
as  2  days  post  overload,  and  this  growth  continued  through  28  days  (Figure  2.2)  to  fully  
surround  the  original  tendon.  Compared  to  controls,  no  significant  differences  in  total  
tendon  CSA  were  observed  at  2  days,  while  there  was  a  dramatic  2.5-­fold  increase  in  
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tendon  CSA  at  7  days,  which  increased  to  3-­fold  at  14  days  and  3.5-­fold  at  28  days  
(Figure  2.3A).  Throughout  the  overload  period,  the  CSA  of  the  original  tendon  matrix  did  
not  change  compared  to  controls  (Figure  2.3B).  The  increase  in  the  CSA  of  the  
neotendon  was  responsible  for  the  overall  increase  in  the  total  tendon  CSA.  While  no  
significant  changes  in  neotendon  CSA  were  observed  at  2  and  7  days  after  overload,  
compared  to  the  value  at  2  days,  the  neotendon  increased  by  4-­fold  at  14  days  and  by  
nearly  5-­fold  at  28  days  (Figure  2.3C).  While  widespread  changes  in  CSA  were  
observed  throughout  the  overload  period,  the  cell  density  in  the  tendon  overall  (Figure  
2.3D),  as  well  as  in  the  original  tendon  (Figure  2.3E)  and  neotendon  (Figure  2.3F)  
regions,  remained  largely  unchanged,  with  a  nearly  2-­fold  decrease  in  cell  density  in  the  
neotendon  at  7  days  compared  to  2  days.    
We  next  sought  to  determine  which  cells  in  the  tendons  were  actively  undergoing  
mitosis  by  labeling  proliferating  cells  with  EdU.  As  shown  in  Figure  2.4A,  the  only  EdU+  
cells  were  observed  in  the  neotendon  region,  and  at  no  time  did  we  detect  EdU+  cells  in  
the  original  tendon.  Additionally,  EdU  was  detected  only  in  scleraxis-­expressing  
fibroblasts  in  the  neotendon,  although  not  every  scleraxis  expressing  fibroblast  was  
EdU+.  In  the  original  tendon,  while  scleraxis  was  not  detected  in  fibroblasts  in  unloaded  
tendons,  mechanical  overload  caused  fibroblasts  to  induce  scleraxis  expression.    
Finally,  we  performed  quantitative  measures  of  scleraxis  and  type  I  collagen  
gene  expression  with  qPCR.  Compared  to  control  tendons,  scleraxis  expression  
increased  nearly  3-­fold  at  2  days,  5.5-­fold  at  7  days,  4-­fold  at  14  days,  and  2.5-­fold  at  28  
days  (Figure  2.5A).  For  type  I  collagen  expression,  compared  to  control  tendons,  no  
   29  
change  was  observed  at  2  days,  but  expression  increased  4-­fold  at  7  days,  7-­fold  at  14  
days,  and  back  down  to  5-­fold  through  28  days  (Figure  2.5B).  
DISCUSSION    
The  results  from  this  study  provide  novel  insight  into  the  cellular  mechanisms  of  
tendon  growth.  The  synergist  ablation  procedure  is  a  commonly  used  technique  used  to  
study  skeletal  muscle  growth  (1,  11),  and  we  postulated  this  approach  could  also  be  
used  to  study  rapid  tendon  growth.  While  many  previous  studies  have  used  chronic  
exercise  training  as  a  model  to  study  tendon  growth  (4),  the  current  study  was  the  first,  
to  our  knowledge,  that  reported  synergist  ablation  as  a  model  to  study  the  rapid  growth  
of  mechanically  overloaded  tendon  tissue.  Additionally,  we  report  novel  findings  
regarding  the  proliferation  capacities  of  cells  in  different  regions  of  the  tendon.  The  
combined  findings  from  the  current  study  suggest  that  synergist  ablation  is  a  useful  
model  to  study  tendon  growth,  and  that  the  fibroblasts  within  the  core  of  the  tendon  do  
not  re-­enter  the  cell  cycle  to  contribute  to  tendon  growth.      
Based  on  morphological  appearance,  Ippolito  (7)  postulated  that  the  fibroblasts  
within  tendon  could  be  divided  into  two  distinct  categories  –  tenoblasts,  which  are  
proliferative  fibroblasts  that  decline  as  organisms  progress  into  adulthood,  and  
tenocytes,  which  are  terminally  differentiated  fibroblasts  that  are  responsible  for  
synthesizing  and  remodeling  the  tendon  ECM.  Although  the  terms  tenoblast  and  
tenocyte  are  often  used  in  the  adult  tendon  literature,  there  is  little  molecular  evidence  
to  support  these  cells  as  having  the  role  ascribed  to  them  by  their  suffix.  However,  
during  early  and  adolescent  development,  using  the  thymidine  analog  IdU,  Tan  and  
colleagues  (21)  demonstrated  that  tendon  contains  approximately  10%  IdU+  cells  at  4  
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weeks  of  age,  and  this  number  decreases  to  approximately  2%  by  8  weeks  of  age.  
Additionally,  there  is  a  gradient  to  this  distribution,  with  the  outer  most  layers  of  the  
tendon  showing  more  IdU+  cells  than  the  midsubstance.  The  work  of  Tan  and  
colleagues  (21)  is  in  agreement  with  Michna  (15)  who  reported  a  cessation  of  growth  in  
rodent  tendons  at  around  10  weeks  of  age.  In  adult  humans,  Heinemeier  and  
colleagues  (5)  used  the  global  increase  in  atmospheric  14C  that  came  about  due  to  
above  ground  nuclear  bomb  testing  to  measure  tissue  growth  rates  in  Achilles  tendons,  
and  found  that  the  core  of  tendon  tissue  appears  to  form  and  stop  growing  by  17  years  
of  age,  with  no  appreciable  changes  in  14C  content  observed  after  this  time  point.  In  this  
study,  we  demonstrate  that  in  response  to  a  mechanical  growth  stimulus,  the  existing  
fibroblasts  within  the  midsubstance  of  tendons  do  not  proliferate  to  contribute  to  tendon  
growth.  Rather,  there  appears  to  be  an  expansion  of  fibroblasts  in  the  outermost  layers  
of  tendon  that  likely  arise  from  a  progenitor  cell  population  in  or  around  the  
epitenon/peritenon  region.  Combined,  the  data  from  the  current  study,  along  with  the  
work  of  Tan  (21)  and  Heinemeier  (5)  suggest  that  the  majority  of  fibroblasts  within  adult  
tendons  are  likely  terminally  differentiated,  and  support  the  use  of  the  term  tenocyte  to  
describe  this  cell  population.  
In  addition  to  identifying  populations  of  proliferative  cells  within  tendon,  this  study  
also  provided  insight  into  the  mechanisms  of  tendon  ECM  synthesis  in  the  context  of  
whole  tendon  growth.  In  Achilles  tendons,  scleraxis  is  expressed  in  nearly  every  
fibroblast  at  2  months  of  age  (13).  By  3  to  4  months  of  age,  scleraxis  expression  
declines  in  most  cells  throughout  the  tendon,  but  persists  in  a  population  of  cells  in  the  
epitenon  (13).  After  supraphysiological  overload,  there  was  an  increase  in  scleraxis  
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positive  cells  in  the  neotendon,  some  of  which  also  were  positive  for  EdU.  Interestingly,  
although  scleraxis  was  detected  in  the  cells  in  the  original  tendon  in  response  to  
overload,  these  cells  did  not  appear  to  be  proliferative.  Further,  cell  density  in  the  
neotendon  was  higher  at  2  days  compared  to  7  days,  and  scleraxis  expression  was  
increased  at  2  days,  which  preceded  the  increase  in  type  I  collagen  expression  at  7  
days.  This  early  expansion  of  cells,  coupled  with  increased  scleraxis  expression,  also  
occurred  before  the  increase  in  CSA  at  7,  14,  and  28  days.  Previous  studies  in  cultured  
tendon  fibroblasts  have  shown  that  scleraxis  expression  is  correlated  with  increased  cell  
proliferation  and  a  reduction  in  scleraxis  is  correlated  with  hypocellular  tendons  (12),  
and  that  scleraxis  directly  regulates  the  expression  of  type  I  collagen  (9).  These  results  
suggest  that  tendon  growth  likely  occurs  initially  through  an  expansion  of  fibroblasts  and  
is  subsequently  followed  by  an  increase  in  ECM  production.  Based  on  in  vitro  studies  of  
tendon  fibroblasts  and  findings  of  the  current  study,  scleraxis  likely  plays  an  important  
role  in  both  of  these  processes.  
While  we  provided  important  insight  into  the  changes  in  scleraxis  expression  
following  supraphysiological  overload,  there  are  several  limitations  to  this  study.  First,  
while  we  show  proliferating  cells  in  the  neotendon,  we  did  not  track  cells  over  time  using  
lineage  tracing  or  dye.  We  also  did  not  measure  TGF-­b  superfamily  signaling  following  
plantaris  overload.  We  focused  on  the  plantaris  tendon,  due  to  the  fact  that  this  is  a  
highly  established  and  simple  synergist  ablation  model,  but  other  tendons  may  behave  
very  differently.  We  visualized  an  abundance  of  scleraxis  positive  cells  in  the  neotendon  
regions  following  overload,  but  did  not  stain  for  other  cell  types  inside  the  neotendon.  
Finally,  a  specific  marker  that  identifies  undifferentiated  tendon  progenitor  cells  in  vivo  is  
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not  yet  known,  and  we  did  not  identify  one  in  this  study.  However,  these  progenitor  cells  
are  likely  to  be  a  type  of  mesenchymal  stem  cell,  as  injection  of  these  cells  into  injured  
mouse  Achilles  tendon  resulted  in  pockets  of  immature  tendon  matrix  formation  (6).    
Tendons  play  an  important  role  in  transmitting  and  storing  force  in  the  
musculoskeletal  system,  and  are  among  the  most  frequently  injured  and  difficult  to  treat  
soft  tissue  injuries  (8).  Despite  the  importance  of  tendons  in  animal  locomotion,  
relatively  little  is  known  about  the  fundamental  cellular  and  molecular  pathways  that  
regulate  tendon  growth.  The  results  from  this  study  indicate  that  there  appear  to  be  at  
least  two  populations  of  cells  that  exist  within  tendon,  and  these  different  populations  
have  altered  responses  following  tendon  mechanical  loading.  Although  inducing  a  
substantial  growth  stimulus  caused  an  overall  increase  in  tendon  CSA,  the  existing  
fibroblasts  within  the  tendon  remained  in  a  terminally  differentiated  state,  and  the  growth  
occurred  entirely  by  the  addition  of  new  cells  and  matrix  in  the  outer-­most  layers  of  the  
tendon.  Along  with  the  work  of  Tan  (21)  and  Heinemeier  (5),  the  results  from  the  current  
study  suggest  that  tendons  in  adult  animals  grow  from  the  most  superficial  layers  out,  in  
a  fashion  similar  to  the  growth  patterns  of  tree  trunks.  Additionally,  gaining  further  
understanding  of  the  fundamental  biology  of  tendon  cell  specification,  proliferation  and  
migration  will  likely  enhance  our  understanding  of  adult  tendon  mechanobiology,  and  
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Figure  2.1.  Representative  image  demonstrating  the  synergist  ablation  model.  The  
Achilles  tendon  is  removed,  leaving  the  plantaris  as  the  sole  plantarflexor  group.  Over  a  
short  period  of  time,  both  the  plantaris  muscle  and  tendon  increase  in  size.    
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Figure  2.2.  Representative  cross-­sections  of  plantaris  tendons  from  control  and  
synergist  ablation  groups.  Sections  stained  with  fast  green  and  hematoxylin.  The  
original  tendon  in  all  groups  subjected  to  synergist  ablation  is  circled  in  a  dashed  line,  
and  the  neotendon  matrix  is  located  superficial  to  this  line.  Scale  bar  for  all  panels  =  
100µm.  
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Figure  2.3.  Quantitative  histomorphometry  of  plantaris  tendons  from  control  and  
synergist  ablation  groups.  CSA  of  the  (A)  total  tendon,  (B)  original  tendon,  and  (C)  
neotendon.  Cell  density  of  the  (D)  total  tendon,  (E)  original  tendon,  and  (F)  neotendon.  
Values  are  mean±SEM.  Differences  were  tested  with  a  one-­way  ANOVA  and  Holm-­
Sidak  post-­hoc  sorting  (P<0.05).  Differences:  *,  from  control;;  #,  from  2d.  
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Figure  2.4.  Representative  immunohistochemistry  of  plantaris  tendons  from  control  and  
synergist  ablation  groups.  (A)  High  magnification  views  of  cells  in  the  original  tendon  
and  neotendon.  Blue,  nuclei  (DAPI);;  Green,  scleraxis-­GFP;;  White,  EdU.  Scale  bar  for  all  
panels  =  50µm.  An  illustration  showing  the  regions  of  interest  is  shown  in  (B).    
  
     
   38  
  
Figure  2.5.  Gene  expression  of  plantaris  tendons  from  control  and  synergist  ablation  
groups.  (A)  Scleraxis  expression  and  (B)  Collagen  type  Iα2  expression.  Target  gene  
expression  was  normalized  to  the  stable  housekeeping  gene  β2-­microglobulin.  Values  
are  mean±SEM.  Differences  were  tested  with  a  one-­way  ANOVA  and  Holm-­Sidak  post-­
hoc  sorting  (P<0.05).  Differences:  *,  from  control;;  #,  from  2d;;  †,  from  7d;;  ‡  from  14d.  
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Tendon  is  organized  into  functional  cable-­like  units  of  primarily  type  I  collagen  
and  transmits  forces  from  muscle  to  bone.  Mechanical  loading  can  increase  tendon  
cross-­sectional  area  (CSA),  but  the  mechanisms  by  which  this  occurs  are  largely  
undetermined.  Scleraxis  is  a  basic  helix-­loop-­helix  transcription  factor  that  plays  a  
central  role  in  the  embryonic  development  of  tendons.  Mice  with  a  targeted  inactivation  
of  scleraxis  fail  to  properly  form  limb  tendons,  but  the  role  that  scleraxis  has  in  
regulating  the  growth  and  adaptation  of  tendons  from  adult  organisms  is  unknown.  Our  
lab  has  previously  used  a  supraphysiological  plantaris  overload  model  in  mice,  by  which  
the  Achilles  tendon  is  removed  and  the  plantaris  is  solely  responsible  for  all  
plantarflexion.  This  causes  rapid  and  robust  growth  of  the  plantaris  tendon  and  is  a  
useful  model  for  the  study  of  post-­natal  tendon  growth.  Using  this  model,  our  lab  has  
previously  demonstrated  that  adult  tendon  grows  from  the  most  superficial  layers-­
outwards,  similar  to  the  rings  of  a  tree.  Early  after  plantaris  overload,  the  tendon  forms  
an  immature  matrix,  or  “neotendon,”  surrounding  the  original  tendon  matrix.  This  
expansion  of  tendon  matrix  corresponds  to  an  increase  in  scleraxis  expression,  and  
most  cells  within  the  neotendon  are  proliferative,  while  cells  in  the  original  tendon  matrix  
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do  not  re-­enter  the  cell  cycle.  Additionally,  the  neotendon  contains  CD146+  pericytes,  a  
class  of  cells  that  surround  blood  vessels  and  are  able  to  become  mesenchymal  
progenitor  cells  in  a  variety  of  tissues.  To  further  determine  the  role  of  scleraxis  in  adult  
tendon  adaptation  to  mechanical  loading,  we  used  a  line  of  mice  that  allowed  for  a  
tamoxifen-­inducible  inactivation  of  scleraxis  (Scx∆/∆),  and  performed  a  plantaris  overload  
procedure.  After  7  or  14  days,  mice  were  euthanized  and  tendons  were  isolated  for  
histological  and  biochemical  measures.  Both  Scx+/+  mice,  and  Scx∆/∆  mice  form  
neotendon  matrices,  however,  compared  to  Scx+/+  mice,  tendons  from  Scx∆/∆  mice  have  
a  much  smaller  neotendon  CSA,  and  reduced  expression  of  many  genes  involved  in  
matrix  synthesis  and  remodeling,  suggesting  the  accumulation  of  tendon  matrix  is  
blunted  in  Scx∆/∆  mice.  The  neotendon  of  Scx∆/∆  mice  have  increased  density  of  CD146+  
cells  compared  to  controls,  and  Scx∆/∆  tendons  have  decreased  expression  of  the  
mature  tendon  marker,  tenomodulin,  suggesting  a  failure  in  differentiation  of  
perivascular  progenitor  cells.  While  further  study  is  necessary,  these  results  suggest  
that  scleraxis  plays  a  pivotal  role  in  the  expansion  of  tendon  matrix  and  differentiation  of  
perivascular  progenitor  cells  towards  the  tendon  lineage  following  mechanical  loading  in  
adult  tendons.    
INTRODUCTION  
Tendons  are  made  up  of  an  extracellular  matrix  (ECM)  containing  primarily  type  I  
collagen,  and  a  surrounding  matrix  of  other  collagens,  elastin,  and  various  
proteoglycans  (4).  The  adult  tendon  is  arranged  in  hierarchical  order,  with  densely  
packed  collagen  fibers  wrapped  by  layers  of  basement  membrane,  making  up  the  
tendon  proper.  Further  wrapping  the  tendon  proper  is  the  outermost  basement  
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membrane  called  the  epitenon,  which  provides  blood  and  nerve  supply  to  the  tendon.  
The  organization  of  the  ECM  allows  the  tendon  to  properly  transmit  forces  from  muscle  
to  bone  and  allow  for  locomotion,  and  respond  to  mechanical  stimuli.  Mechanical  
loading  can  increase  tendon  cross  sectional  area  (CSA)  up  to  30%  (17)  and  improve  
tendon  mechanical  properties  (13),  but  the  cellular  and  molecular  mechanisms  that  
allow  this  to  occur  are  largely  unknown.  Work  in  recent  years  has  identified  many  
factors  that  may  play  a  role  in  the  embryonic  development  of  tendon,  which  have  been  
useful  to  identify  those  that  may  be  important  for  the  adaptation  of  tendon  in  adult  
animals  (10).    
Scleraxis  (Scx)  is  a  basic  helix-­loop-­helix  (bHLH)  transcription  factor  that  was  first  
discovered  in  the  early  stages  of  tendon  development,  and  robustly  marked  tendon  cells  
in  the  embryo  (24).  Currently,  scleraxis  is  the  earliest  detectible  marker  for  differentiated  
tendon  cells,  (9)  and  activates  downstream  tendon  differentiation  genes  such  as  
Collagen  1α1  (Col1a1)  and  Tenomodulin  (Tmnd)  through  its  interaction  with  the  bHLH  
transcription  factor,  E47  (3,  15,  26).  Loss  of  scleraxis  results  in  the  loss  or  severe  
disruption  of  long  tendons  throughout  the  body  (19),  and  leads  to  the  absence  of  bone  
ridges  that  allow  for  the  attachment  of  tendons  to  bone  (29).  Additionally,  the  expression  
of  later  stage  tendon  markers  is  dramatically  reduced,  including  tenomodulin  (Tnmd)  
which,  to  date,  is  perhaps  the  best  late  stage  differentiation  marker  of  tendon.  Scleraxis  
is  robustly  expressed  through  birth  and  early  postnatal  period,  but  scleraxis  expression  
is  limited  to  the  epitenon  in  adult  animals  (17).  Mechanical  loading  increases  scleraxis  
expression  and  promotes  the  proliferation  of  scleraxis+  cells  in  the  epitenon,  which  
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correlates  to  increased  type  I  collagen  expression  and  increased  CSA  of  the  tendon  (7,  
17).    
Previously,  our  group  utilized  a  new  model  of  tendon  growth,  whereby  the  
Achilles  tendon  is  removed,  causing  the  synergist  plantaris  tendon  to  undergo  a  robust  
increase  in  CSA  (7,  20).  This  loading  model  causes  expansion  of  the  tendon  matrix  
outward,  through  the  development  of  a  newly  synthesized  immature  tendon  matrix,  or  
neotendon.  The  neotendon  contained  a  large  population  of  proliferative  scleraxis+  cells,  
which  corresponded  to  elevations  in  scleraxis  transcript  in  the  whole  tendon.  In  a  rat  
model  of  synergist  ablation,  the  neotendon  also  contains  a  population  of  CD146+  cells  
(23).  Pericytes,  or  perivascular  stem  cells,  are  a  population  of  multipotent  stem  cells  
surrounding  small  vessels  and  are  capable  of  differentiation  into  many  types  of  
mesenchymal  cells,  including  fibroblasts.  CD146+  pericytes  have  been  observed  within  
tendon,  and  these  cells  appear  to  participate  in  tendon  ECM  regeneration  (14,  28),  and  
the  mechanisms  by  which  pericytes  may  participate  in  tenogenic  differentiation  and  
subsequent  matrix  production  is  unknown.  
Despite  the  load  applied  on  the  plantaris  tendon  in  the  synergist  ablation  model,  
cells  within  the  original  tendon  matrix  do  not  re-­enter  the  cell  cycle,  suggesting  the  
original  tendon  area  does  not  turn  over  much,  if  at  all.  This  is  in  agreement  with  human  
studies,  where  the  core  tendon  matrix  does  not  turn  over  past  roughly  17  years  of  age  
(8).  Consistent  with  this,  in  mice,  scleraxis  is  robustly  expressed  in  the  original  tendon  
matrix  until  early  adulthood,  but  is  undetectable  following  this  time  (17).  Scleraxis  
therefore  may  be  critically  important  for  proper  tendon  tissue  turnover  and  maintenance  
in  the  early  stages  of  life,  and  the  lack  of  scleraxis  in  the  tendon  proper  contributes  to  
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decreased  tendon  turnover  during  adulthood.  Given  that  scleraxis  is  dramatically  
elevated  following  synergist  ablation  in  adult  animals  (7),  we  sought  to  investigate  
whether  scleraxis  was  required  for  the  growth  and  adaptation  of  adult  tendons  during  
this  process.  We  generated  a  line  of  mice  that  allow  for  the  conditional  inactivation  of  
scleraxis  (Scxflox/flox:Rosa26CreERT2,  or  Scx∆/∆)  to  test  the  hypothesis  that  scleraxis  was  
required  for  adult  tendon  growth  following  synergist  ablation.    
METHODS  
Animals.  This  study  was  approved  by  the  University  of  Michigan  IACUC.  Four  to  
six-­month-­old  mice  (N=10  per  group)  were  used  in  this  study.  A  line  of  transgenic  mice  
containing  loxP  sites  flanking  exon  1  of  scleraxis  (Scxflox/flox)  were  kindly  provided  by  Dr.  
Ronen  Schweitzer  and  crossed  to  a  line  of  mice  that  expressed  CreERT2  under  the  
control  of  the  Rosa26  promoter  (R26CreERT2/CreERT2,  The  Jackson  Laboratory,  
Farmington,  CT),  generating  mice  that  allowed  for  the  conditional  inactivation  of  
scleraxis  by  tamoxifen  (Scx∆/∆,  Figure  3.1A).  Mice  were  given  tamoxifen  (2mg/day,  
Sigma-­Aldrich,  St.  Louis,  MO)  via  intraperitoneal  injection  5  days  prior  to  synergist  
ablation,  and  daily  until  sacrifice.  Synergist  ablation  surgery  was  performed  as  
described  previously  (7).  Briefly,  an  approximately  3-­4mm  piece  of  the  Achilles  tendon  
was  removed  from  each  hindlimb  to  overload  the  synergist  plantaris  tendon.  After  
recovery,  mice  were  given  post-­operative  buprenorphine  (0.05mg/kg)  and  returned  to  
their  cages.  Mice  were  allowed  to  ambulate  freely  for  7  or  14  days  following  synergist  
ablation.  We  chose  these  time  points  because  scleraxis  expression  was  highest  at  this  
time  in  a  previous  study  (7).  Plantaris  tendons  were  removed  and  prepared  for  either  
DNA  isolation,  histology,  electron  microscopy,  or  RNA  isolation.  A  separate  cohort  of  
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animals  was  used  for  in  vitro  studies.  Age-­matched  wild  type  mice  were  used  as  
controls  (Scx+/+),  and  received  the  same  doses  of  tamoxifen  to  control  for  the  effect  of  
the  treatment  on  normal  tendon  function.    
DNA  isolation.  Portions  of  proximal  plantaris  tendons  were  isolated  and  prepared  
for  DNA  isolation  using  the  DNeasy  Blood  &  Tissue  Kit  (Qiagen,  Valencia,  CA).  DNA  
was  amplified  via  qPCR  with  custom  primers  for  Scx  exon  1  
(Fwd:5’GACCGCAAGCTCTCCAAGAT3’;;  Rev:5’ACGACCGCTGTGGAAGAAAG3’)  and  
exon  2  (Fwd:5’CGCAGGTCCCCAAGAGCACG3’;;  
Rev:5’GGCCTGGGTCAGTGTTCGGC3’).  Knockdown  efficiency  was  calculated  by  
measuring  the  change  in  exon  1  genomic  DNA  relative  to  exon  2  gDNA  using  the  2-­∆Cq  
method  (22).  Scx∆/∆  tendons  exhibited  approximately  a  96%  reduction  in  exon  1  gDNA  
compared  to  controls  (Figure  3.1B).    
Histology.  Distal  plantaris  tendons  were  snap  frozen  in  liquid  nitrogen  cooled  
isopentane  and  stored  at  -­80ºC  until  use.  Tendons  were  sectioned  and  stained  with  fast  
green  and  hematoxylin  as  described  previously  (7).  Fast  Green  and  hematoxylin  
sections  were  imaged  on  a  Olympus  BX  microscope  (Olympus,  Center  Valley,  PA).  For  
immunohistochemistry,  tendons  were  sectioned  and  permeabilized  in  Triton-­X-­100  
(0.02%)  and  blocked  with  5%  goat  serum.  Sections  were  incubated  overnight  in  primary  
antibody  against  CD146  (AbCam,  San  Francisco,  CA)  and  then  incubated  in  secondary  
antibody  conjugated  to  Alexa  Fluor  555.  Samples  were  also  stained  with  DAPI  and  
wheat  germ  agglutinin  conjugated  to  Alexa  Fluor  488.  Images  were  taken  on  a  Nikon  A-­
1  confocal  microscope  equipped  with  a  high-­resolution  camera  (Nikon,  Tokyo,  Japan).  
Images  were  imported  into  ImageJ  for  histomorphametric  measures.  Cell  density  was  
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calculated  by  the  number  of  nuclei  per  unit  area  of  the  tendon.  The  percentage  of  
CD146+  cells  was  measured  by  the  total  number  of  CD146+/DAPI+  cells  in  the  
neotendon  normalized  by  the  number  of  CD146-­/DAPI+  cells.    
Transmission  Electron  Microscopy.  Proximal  tendon  portions  were  fixed  in  1%  
tannic  acid,  1%  glutaraldehyde  in  Sorenson’s  buffer,  followed  by  post-­fixation  in  2%  
osmium  tetroxide  (Electron  Microscopy  Sciences,  Hatfield,  PA).  Samples  were  then  
dehydrated  using  a  graded  ethanol  series  and  embedded  in  EMBed  812  resin  using  a  
graded  resin  and  propylene  oxide  series.  One  micron  transverse  sections  were  cut  with  
a  diamond  knife  ultramicrotome,  and  imaged  using  a  JEOL  1400-­plus  transmission  
electron  microscope  with  a  high-­resolution  AMT  digital  camera  (JEOL  USA,  Peabody,  
MA).    
Tendon  RNA  Isolation.  Plantaris  tendons  were  isolated,  snap  frozen,  and  stored  
at  -­80ºC  until  use.  On  the  day  of  RNA  isolation,  tendons  were  homogenized  immediately  
in  QIAzol  and  isolated  using  a  micro  RNeasy  kit  (Qiagen).  RNA  concentration  was  
determined  using  a  NanoDrop  2000  (Thermo  Fisher  Scientific,  Waltham,  MA).  
RNA  Sequencing  (RNASeq).  Approximately  200-­400ng  total  RNA  per  sample  
was  delivered  to  the  University  of  Michigan  Sequencing  Core  for  RNA  sequencing.  
Sample  concentrations  were  normalized  and  cDNA  pools  were  created  for  each  
sample,  and  then  subsequently  tagged  with  a  barcoded  oligo  adapter  to  allow  for  
sample  specific  resolution.  Sequencing  was  carried  out  using  an  Illumina-­HiSeq  
platform  (Illumina,  San  Diego,  CA)  and  50bp  single  end  reads.  Raw  RNASeq  data  was  
uploaded  into  BaseSpace  (Illumina)  for  adapter  trimming,  quality  control,  and  alignment.  
Reads  were  mapped  to  the  mm10  genome  assembly  (UCSC,  Santa  Cruz,  CA)  using  
   48  
the  STAR  aligner  (Illumina)  and  differential  expression  analysis  was  performed  using  
the  DESeq2  application  (Illumina).    
Tendon  fibroblast  culture.  Tail  tendons  were  isolated  from  Scxflox/flox:R26CreERT2  
mice  and  cultured  as  described  previously  (16).  Tendon  fascicles  were  carefully  isolated  
from  tail  tendons,  minced,  and  placed  in  DMEM  with  0.2%  type  II  collagenase  
(Invitrogen,  Carlsbad,  CA)  for  1h  at  37°C  with  agitation.  After  dissociation,  samples  
were  centrifuged  and  resuspended  in  media  containing  10%  FBS  and  1%  antibiotic-­
antimycotic  (ABAM,  Invitrogen)  and  plated  on  100-­mm  type  I  collagen  coated  dishes  
(BD  Biosciences,  San  Jose,  CA).  Fibroblasts  were  passaged  upon  reaching  70%  
confluence  onto  6-­well  dishes  coated  with  type  I  collagen  (BD  Biosciences),  and  media  
was  switched  to  DMEM  containing  2%  horse  serum  and  1%  ABAM.  Cells  were  split  into  
two  groups,  a  group  that  received  10μM  4-­hydroxytamoxifen  (4HT,  Sigma),  and  a  group  
that  received  an  equivalent  volume  of  DPBS  (Thermo  Fisher).  Upon  reaching  70%  
confluence,  each  group  (-­4HT  or  +4HT)  was  either  supplemented  with  2  ng/ml  of  
recombinant  human  Transforming  Growth  Factor  beta  1  (TGF-­β1  or  TGFβ,  R&D  
Systems),  or  in  equivalent  volumes  of  DPBS  (Thermo  Fisher)  for  2  h.  Following  
treatment,  cells  were  scraped  from  their  dishes  and  prepared  for  total  RNA  isolation  
using  the  RNeasy  micro  kit  (Qiagen).  A  separate  cohort  of  cells  were  isolated,  grown  to  
70%  confluence,  and  treated  with  or  without  4HT  for  Scx  gDNA  content.  Cells  treated  
with  4HT  had  dramatically  decreased  Scx  exon  1  gDNA  content  compared  to  cells  not  
treated  with  4HT  (Figure  3.1C).  
Statistics.  Differences  between  groups  were  measured  using  Two-­way  ANOVAs  
(α=0.05),  followed  by  Fishers  LSD  post  hoc  sorting,  except  for  knockdown  efficiency  
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calculations,  which  were  tested  using  t-­tests  (α=0.05).  Analyses  were  performed  using  
Prism  6.0  (GraphPad  Software,  La  Jolla,  CA).  Values  are  presented  as  mean+SD.  
RESULTS  
   Following  synergist  ablation,  there  was  a  dramatic  increase  in  the  size  of  the  
plantaris  tendon  in  Scx+/+  animals,  through  the  induction  of  a  neotendon  matrix  (Figure  
3.2A,B).  The  original  tendon  area  did  not  change  between  groups  (Figure  3.2B),  but  
total  tendon  CSA  was  decreased  in  mutant  animals,  due  to  a  dramatically  blunted  
neotendon  compared  to  controls  (Figure  3.2A,B).  There  were  modest  differences  in  total  
tendon  cell  density  between  genotypes  at  7D,  with  a  slightly  reduced  cell  density  in  the  
Scx∆/∆  animals  compared  to  controls  (Figure  3.2C).  There  was  a  slight  increase  in  cell  
density  of  the  neotendon  at  14D  in  Scx∆/∆  animals  compared  to  controls  (Figure  3.2C).  
   Electron  micrographs  were  used  to  examine  the  structural  differences  in  tendon  
between  genotypes.  There  were  no  appreciable  differences  in  fibril  CSA  or  distribution  
between  genotyped  for  fibrils  within  the  original  tendon  matrix  (Figure  3.3A).  In  Scx+/+  
animals,  there  was  evidence  of  collagen  fibril  formation  within  neotendon  tissue,  and  the  
fibrils  were  arranged  along  the  axis  of  force  transmission  (Figure  3.3B).  Conversely,  
neotendons  from  Scx∆/∆  mice  exhibited  disrupted  collagen  alignment,  where  many  fibrils  
were  assembled  perpendicular  to  the  axis  of  force  transmission  (Figure  3.3B).  There  
were  still  pockets  of  aligned  collagen  fibrils  in  Scx∆/∆  mice,  but  not  to  the  level  of  controls  
(Figure  3.3B).  
   We  measured  the  expression  of  several  transcripts  related  to  ECM  production,  
ECM  turnover,  and  cellular  differentiation  with  RNASeq.  The  expression  of  type  I  
(Col1a1,  Col1a2)  and  type  XII  collagen  (Col12a1)  was  decreased  between  genotypes  at  
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each  time  point,  but  there  were  no  changes  in  the  expression  of  type  III  collagen  
(Col3a1)  with  time  or  between  groups  (Figure  3.4A).  There  was  a  dramatic  decrease  of  
matrix  metalloproteinase  (MMP)  -­9  (Mmp9),  and  a  decrease  of  MMP14  (Mmp14)  at  7D  
in  Scx∆/∆  mice  compared  to  controls,  despite  a  decrease  in  tissue  inhibitor  of  
metalloproteinases-­1  (TIMP1,  Timp1)  in  mutant  animals  at  7D  and  decreases  in  TIMP2  
(Timp2)  expression  at  14D  in  Scx∆/∆  mice  compared  to  controls  (Figure  3.4B).  There  
were  decreases  in  MMP9  and  MMP14  across  genotypes  at  14D  compared  to  7D  
(Figure  3.4B).  The  expression  of  other  ECM  proteins  were  altered  with  the  loss  of  
scleraxis,  including  hyaluronic  acid  synthase  2  (Has2),  which  was  decreased  in  Scx∆/∆  
mice  compared  to  controls  at  7D,  and  fibromodulin  (Fmod),  which  was  decreased  in  
Scx∆/∆  mice  across  both  time  points  compared  to  Scx+/+  mice  (Figure  3.4C).  Additionally,  
the  expression  of  thrombospondin-­1  (Thbs1)  was  decreased  in  mutant  animals  
compared  to  controls  at  each  time  point,  and  fibronectin  (Fn1)  was  decreased  in  Scx∆/∆  
mice  compared  to  controls  at  14D  (Figure  3.4C).  As  expected,  there  was  a  dramatic  
decrease  in  Scx  transcript  in  mutant  mice  compared  to  controls,  and  the  expression  of  
Scx  decreased  at  14D  compared  to  7D  in  control  animals  (Figure  3.4D).  Tnmd  was  
decreased  in  mutant  animals  compared  to  controls  in  both  time  points,  and  there  was  
no  change  in  Sox9  expression  between  genotypes  at  either  time  point  (Figure  3.4D).  
The  expression  of  apolipoprotein-­E  (Apoe)  was  increased  in  Scx∆/∆  mice  compared  to  
Scx+/+  mice  at  7D  (Figure  3.4D).    
   The  role  of  scleraxis  on  tendon  fibroblast  activity  was  also  tested  in  vitro.  Loss  of  
scleraxis  did  not  affect  the  proliferative  capacity  of  tendon  fibroblasts  (Figure  3.5A).  
TGFβ  is  a  known  activator  of  scleraxis  (18),  and  treatment  of  tendon  fibroblasts  resulted  
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in  the  increase  in  many  genes  related  to  tendon  cell  differentiation  and  matrix  
production,  including  Scx,  Tnmd,  Col1a2,  and  Eln  (Figure  3.5B).  Loss  of  scleraxis  
resulted  in  decreased  expression  of  all  transcripts  with  addition  of  TGFβ  (Figure  3.5B).    
Using  immunohistochemistry,  we  measured  the  abundance  of  CD146+  cells  
within  the  neotendon  of  overloaded  plantaris  tendons.  There  was  an  abundance  of  
CD146+  cells  in  the  neotendon  in  both  genotypes  (Figure  3.6A).  Compared  to  Scx+/+  
mice,  there  was  a  dramatic  increase  in  the  percentage  of  CD146+  cells  in  the  
neotendons  of  Scx∆/∆  mice  across  each  time  point  (Figure  3.6B).  No  differences  
between  time  points  were  observed  for  either  genotype.    
DISCUSSION  
Unlike  other  neighboring  mesenchymal  tissues,  the  mechanisms  behind  post-­
natal  tendon  growth  is  poorly  understood.  Previously,  using  the  synergist  ablation  
model,  we  identified  the  formation  of  a  neotendon  matrix  that  develops  around  the  
original  tendon  matrix,  and  this  new  matrix  was  populated  with  proliferative,  scleraxis  
expressing  cells  (7).  The  aim  of  this  study  was  to  identify  whether  scleraxis  was  
required  for  the  adaptation  of  tendon  to  mechanical  loading.  The  results  indicate  that  not  
only  is  scleraxis  required  for  the  proper  expansion,  formation,  and  remodeling  of  tendon  
ECM  during  mechanical  loading,  but  scleraxis  may  also  possess  a  previously  unknown  
role  in  the  fate  determination  of  a  population  of  perivascular  tendon  stem  cells.  While  
further  study  is  needed  to  fully  elucidate  the  role  of  scleraxis  in  differentiating  stem  cells,  
this  study  provided  substantial  insight  into  the  role  of  scleraxis  in  tendon  growth  and  
remodeling.    
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It  has  long  been  suggested  that  tendon  possessed  a  compartment  of  stem-­like  
cells  that  could  participate  in  tendon  regeneration  (5,  12),  but  the  location  of  these  cells  
was  unknown.  Recent  work  describes  a  compartment  of  perivascular  stem  cells  
expressing  CD146  located  in  tendon,  which  may  be  involved  in  the  regeneration  of  
tendon  following  injury  or  mechanical  loading  (14,  23,  28).  In  a  rat  model  of  patellar  
tendon  injury  and  repair,  these  cells  participate  in  tenogenic  differentiation  when  
stimulated  with  connective  tissue  growth  factor  (CTGF)  (14).  In  the  patellar  tendon,  
approximately  0.8%  of  cells  are  CD146+,  which  is  consistent  with  the  relatively  low  
amount  of  vasculature  within  resting  tendon  (14).  Previous  studies  in  our  laboratory  
using  the  synergist  ablation  model  in  rats  showed  that  these  cells  appear  to  migrate  
from  their  niche  in  the  vasculature  and  proliferate  within  the  neotendon  (23).  In  the  
current  study,  in  wild  type  animals,  the  percentage  of  CD146+  cells  can  reach  almost  
30%  in  the  newly  developing  neotendon  region,  and  reaches  almost  double  this  value  
with  the  loss  of  scleraxis.  The  gain  in  CD146+  cells  in  the  absence  of  scleraxis  raises  a  
very  intriguing  new  role  for  scleraxis  biology,  as  a  lack  of  differentiated  cells  in  the  
neotendons  of  Scx∆/∆  mice  can  indicate  an  inability  of  these  cells  to  fully  differentiate  into  
mature  tendon  cells.  Consistent  with  this  was  a  dramatic  decrease  in  tenomodulin  
transcript.  Tenomodulin  is  to  date  the  best  marker  of  a  differentiated  tendon  cell  (6,  10),  
and  is  regulated,  at  least  in  part,  by  scleraxis  (27).  Like  scleraxis,  TGFβ  may  also  
regulate  tenomodulin,  as  both  tenomodulin  and  scleraxis  transcripts  are  completely  lost  
in  Tgfbr2-­/-­  and  Tgfbr3-­/-­  mice  (21).  Scx∆/∆  cells  in  the  current  study  had  blunted  
tenomodulin  expression  when  stimulated  with  TGFβ  in  culture,  indicating  that  scleraxis  
also  plays  a  role  in  the  TGFβ-­induced  expression  of  tenomodulin.  Animals  deficient  in  
   53  
tenomodulin  have  disrupted  tendon  fibril  maturation  (6),  which  is  apparent  in  the  
disordered  fibrils  within  the  neotendon  of  mutant  mice  in  the  current  study.  There  were  
no  changes  between  groups  in  Sox9  expression,  a  chondrogenic  marker,  suggesting  no  
increase  in  chondrogenesis  with  the  loss  of  scleraxis.  However,  there  was  a  substantial  
increase  in  the  expression  of  ApoE  in  mutant  mice  at  7D,  which  could  increase  
cholesterol  deposition  in  the  tendon,  making  tendon  more  susceptible  to  injuries  and  
tendinopathy  (2,  25).  The  results  from  this  study  have  led  to  a  new  model  of  tendon  
adaptation  and  regeneration  that  involves  the  activation  and  differentiation  of  resident  
CD146+  stem  cells,  which  can  migrate  from  their  niche  to  participate  in  tendon  
remodeling  through  the  activation  of  scleraxis  (Figure  3.7A).  Removal  of  scleraxis  
renders  a  buildup  of  stem  cells  that  have  diminished  tenogenic  differentiation  capacity  
(Figure  3.7B).  
Scleraxis  has  a  very  well  defined  role  in  the  development  of  tendon  in  the  
embryo,  and  Scx-­/-­  mice  have  a  severely  disrupted  tendon  phenotype  (19).  Scleraxis  
has  been  shown  to  activate  the  expression  of  type  I  collagen  (15),  tenomodulin  (6,  27,  
30),  and  fibronectin  (1).  Mechanical  loading  increases  the  expression  of  scleraxis,  type  I  
collagen,  and  tenomodulin  in  tendon  (7,  18),  and  transcriptomic  analysis  identified  a  
decrease  in  collagen1α1,  collagen1α2,  tenomodulin,  and  fibronectin,  among  others  in  
Scx∆/∆  mice  following  synergist  ablation.  Additionally,  TGFβ  is  a  potent  activator  of  
scleraxis,  type  I  collagen,  and  tenomodulin  in  vitro  (18),  and  the  loss  of  scleraxis  
decreases  the  effect  of  TGFβ  on  all  of  these  transcripts  in  the  current  study.  These  
results  clearly  show  that  the  effects  of  both  mechanical  loading  as  well  as  TGFβ  on  the  
expression  of  downstream  tendon  fibroblast  markers  are  regulated  by  scleraxis.    
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Within  the  developmental  literature,  it  is  thought  that  scleraxis  may  not  be  the  
master  regulator  of  the  tendon  cell  fate  (10),  and  this  seems  to  be  conserved  in  
adulthood.  Despite  decreases  in  many  downstream  tendon  markers  in  Scx∆/∆  mice,  their  
expression  was  not  completely  ablated,  and  the  expression  of  other  ECM  components  
were  unchanged,  such  as  type  III  collagen.  Additionally,  while  blunted,  Scx∆/∆  mice  still  
developed  a  small  neotendon  with  some  tendon  fibrils  in  alignment  among  the  many  in  
disarray.  There  are  several  possible  mechanisms  to  account  for  this,  including  a  
compensatory  mechanism  that  accounts  for  the  loss  in  scleraxis,  or  likely  an  upstream  
tenogenic  differentiation  factor  which,  prior  to  the  induction  of  scleraxis,  activates  an  
initial  expansion  of  matrix  following  mechanical  loading.    
Despite  providing  substantial  new  insight  into  the  role  of  scleraxis  in  adult  tendon  
adaptation,  this  study  is  not  without  limitation.  We  only  used  two  time  points  following  
overload  to  study  scleraxis  function.  We  chose  these  time  points  as  they  were  the  
highest  in  scleraxis  expression  in  a  previous  study  using  the  same  tendon  growth  model  
(7).  It  would  be  useful  to  assess  the  effects  of  a  loss  in  scleraxis  before  and  after  these  
time  points.  While  we  showed  that  CD146+  stem  cells  are  likely  activated  by  scleraxis  
for  tenogenic  differentiation,  we  did  not  test  this  with  lineage  tracing.  We  also  did  not  
measure  the  direct  activation  of  the  TGFβ  signaling  pathway  following  synergist  ablation  
in  mutant  animals.  Lastly,  while  this  model  is  an  extremely  useful  one  to  study  
mechanical  load-­induced  tendon  growth,  the  model  only  assesses  changes  in  the  
plantaris  tendon,  where  other  tendons  in  the  body  may  behave  differently.  
Tendons  connect  muscle  to  bone,  and  are  often  overlooked  in  the  literature  due  
to  their  relative  hypocellularity  and  difficulty  as  a  tissue  to  work  with.  However,  tendon  
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injuries  and  painful  tendinopathies  are  a  significant  healthcare  problem,  and  treatment  
options  are  limited  to  many  conservative  therapies,  or  painful  surgeries.  Tendinosis  is  a  
painful,  chronic  condition  which  is  thought  to  occur  due  to  the  failure  of  fibroblasts  to  
maintain  and  synthesize  ECM  (11).  Understanding  the  basic  mechanisms  of  tendon  
adaptation  to  injury  or  mechanical  loading  will  undoubtedly  inform  future  treatments  
towards  tendinopathy.  The  lack  of  scleraxis  in  mice  results  in  an  inability  to  produce  a  
proper  increase  in  ECM  to  respond  to  increased  loads.  If  the  function  of  scleraxis  also  
translates  to  humans,  it  is  conceivable  that  a  lack  of  scleraxis  in  patients  would  result  in  
the  inability  of  fibroblasts  to  sense  loads  and  maintain  matrix  homeostasis,  leading  to  
painful  tendinopathy.  In  addition  to  the  expansion  of  knowledge  in  fundamental  scleraxis  
biology,  the  results  from  this  study  offer  a  new  and  unique  perspective  to  the  function  of  
scleraxis  in  tendon  progenitor  cells,  which  also  requires  further  study  in  human  tendon  
tissue.  While  more  study  is  needed,  these  results  indicate  that  scleraxis  may  be  an  
attractive  therapeutic  target  for  individuals  with  painful  tendinopathies  to  rescue  ECM  
production  in  tendinopathic  tendons  and  improve  quality  of  life.  
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Figure  3.1.  Overview  of  model  to  generate  Scx∆/∆  mice.  (A)  Scx∆/∆  mouse  model  used  
that  allowed  for  the  conditional  inactivation  of  scleraxis  in  this  study.  (B)  Relative  
abundance  of  scleraxis  exon  1  genomic  DNA  in  wild  type  or  Scx∆/∆  mice.  Data  are  
presented  mean+SD.  *,  Different  from  Scx+/+  (P  <0.05)  (C)  Relative  abundance  of  
scleraxis  exon  1  genomic  DNA  in  tendon  fibroblasts  from  R26RCreERT2:Scxflox/flox  
mice  treated  with  or  without  4-­hydroxy-­tamoxifen  (4HT).  Data  are  presented  
mean+SD.  *,  Different  from  -­4HT  (P  <0.05).  
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Figure  3.2.  Histology  and  histomorphometric  measures  of  Scx+/+  and  Scx∆/∆  mice  
after  plantaris  overload.  (A)  Representative  fast  green  stained  plantaris  tendons  from  
Scx+/+  and  Scx∆/∆  mice  following  7  or  14  days  plantaris  overload.  Black  outline  
indicates  original  tendon  area  (B)  Quantification  of  cross  sectional  area  (CSA)  in  the  
whole  tendon,  original  tendon,  or  neotendon  of  Scx+/+  and  Scx∆/∆  mice  following  7  or  
14  days  plantaris  overload.  (C)  Quantification  of  cell  density  in  the  whole  tendon,  
original  tendon,  or  neotendon  of  Scx+/+  and  Scx∆/∆  mice  following  7  or  14  days  
plantaris  overload.  Data  are  presented  mean+SD.  a,  Different  from  7D  Scx+/+;;  b,  
Different  from  7D  Scx∆/∆;;  c,  Different  from  14D  Scx+/+  (P  <0.05).    
   58  
  
  
Figure  3.3.  Electron  micrographs  of  Scx+/+  and  Scx∆/∆  mice  after  plantaris  overload.  
(A)  Representative  electron  microscopy  (EM)  images  of  tendon  fibrils  within  the  
original  tendon  of  Scx+/+  and  Scx∆/∆  mice  following  7  or  14  days  plantaris  overload.  (B)  
Representative  electron  microscopy  (EM)  images  of  collagen  fibrils  in  the  neotendon  
of  Scx+/+  and  Scx∆/∆  mice  following  7  or  14  days  plantaris  overload.  
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Figure  3.4.  Expression  of  transcripts  measured  by  RNA  Sequencing  in  Scx+/+  and  
Scx∆/∆  mice  after  plantaris  overload.  Transcripts  related  to  (A)  collagen  synthesis,  (B)  
matrix  metalloproteinase  and  tissue  inhibitor  of  metalloproteinase,  (C)  other  ECM  
components  such  as  SLRP,  glycoprotein,  and  glycosaminoglycan  synthesis,  and  (D)  
cellular  differentiation.  Data  are  presented  mean+SD.  a,  Different  from  7D  Scx+/+;;  b,  
Different  from  7D  Scx∆/∆;;  c,  Different  from  14D  Scx+/+  (P  <0.05).    
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Figure  3.5.  Expression  of  genes  related  to  tendon  fibroblast  differentiation  and  ECM  
synthesis  in  isolated  tendon  fibroblasts  from  R26RCreERT2:Scxflox/flox  mice  treated  
with  or  without  4-­hydroxy-­tamoxifen  (4HT)  and  in  response  to  TGFβ  treatment.  Data  
are  presented  mean+SD.  a,  Different  from  -­4HT/-­TGFβ;;  b,  Different  from  +4HT/-­
TGFβ;;  c,  Different  from  -­4HT/+TGFβ  (P  <0.05).  
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Figure  3.6.  Quantification  of  CD146+  cells  in  the  neotendon  of  Scx+/+  and  Scx∆/∆  mice  
following  plantaris  overload.  (A)  Representative  immunohistochemistry  image  from  
Scx+/+  and  Scx∆/∆  mice  showing  the  location  of  CD146+  cells  in  the  neotendon.  OT,  
original  tendon;;  NT,  neotendon.  Nuclei  (blue),  ECM  (red),  CD146+  cells  (yellow).  
White  outline  indicates  border  of  original  tendon  and  neotendon.  White  arrows  
indicate  CD146+  cell  in  the  neotendon.  (B)  Quantification  of  CD146+  cells  in  the  
neotendon.  Data  are  presented  mean+SD.  a,  Different  from  7D  Scx+/+;;  b,  Different  
from  7D  Scx∆/∆;;  c,  Different  from  14D  Scx+/+  (P  <0.05).    
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Figure  3.7.  Proposed  model  of  scleraxis  function  in  CD146+  perivascular  stem  cells.  
In  wild-­type  mice  (left),  scleraxis  helps  direct  the  differentiation  of  CD146+  cells  into  a  
tenogenic  lineage.  When  scleraxis  is  lost  (right),  CD146+  cells  buildup  in  an  un-­
differentiated  state  which  may  undergo  aberrant  differentiation  or  remain  un-­
differentiated,  rendering  the  cell  unable  to  participate  in  normal  ECM  maintenance  
and  synthesis.    
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Mitochondrial  Dysfunction  and  Impaired  in  Muscle  Regeneration  in  Myosteatosis    
  
ABSTRACT  
Myosteatosis  is  the  pathological  accumulation  of  lipid  that  occurs  in  conjunction  
with  atrophy  and  fibrosis  following  skeletal  muscle  injury  or  disease.  Little  is  known  
about  the  mechanisms  by  which  lipid  accumulates  in  myosteatosis,  but  many  studies  
have  demonstrated  the  degree  of  lipid  infiltration  negatively  correlates  with  muscle  
function  and  regeneration.  Our  goal  was  to  identify  biochemical  pathways  that  lead  to  
muscle  dysfunction  and  lipid  accumulation  in  injured  rotator  cuff  muscles,  a  model  that  
demonstrates  severe  myosteatosis.  Adult  rats  were  subjected  to  a  massive  tear  to  the  
rotator  cuff  musculature.  After  a  period  of  either  0  (healthy  control),  10,  30,  or  60  days,  
muscles  were  prepared  for  RNA  sequencing,  shotgun  lipidomics,  metabolomics,  
biochemical  measures,  electron  microscopy,  and  muscle  fiber  contractility.  Following  
rotator  cuff  injury,  there  was  a  decrease  in  muscle  fiber  specific  force  production  that  
was  lowest  at  30d.  There  was  a  dramatic  time  dependent  increase  in  triacylglyceride  
content.  Interestingly,  genes  related  to  not  only  triacylglyceride  synthesis,  but  also  lipid  
oxidation  were  largely  downregulated  over  time.  Using  bioinformatics  techniques,  we  
identified  that  biochemical  pathways  related  to  mitochondrial  dysfunction  and  reactive  
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oxygen  species  were  considerably  increased  in  muscles  with  myosteatosis.  Long  chain  
acyl-­carnitines  and  L-­carnitine,  precursors  to  beta-­oxidation,  were  depleted  following  
rotator  cuff  tear.  Electron  micrographs  showed  injured  muscles  displayed  large  lipid  
droplets  within  mitochondria  at  early  time  points,  and  an  accumulation  of  peripheral  
segment  mitochondria  at  all  time  points.  Several  markers  of  oxidative  stress  were  
elevated  following  rotator  cuff  tear.  The  results  from  this  study  suggest  that  the  
accumulation  of  lipid  in  myosteatosis  is  not  a  result  of  canonical  lipid  synthesis,  but  
occurs  due  to  decreased  lipid  oxidation  in  mitochondria.  A  failure  in  lipid  utilization  by  
mitochondria  would  ultimately  cause  an  accumulation  of  lipid  even  in  the  absence  of  
increased  synthesis.  Further  study  will  identify  whether  this  process  is  required  for  the  
onset  of  myosteatosis.  
INTRODUCTION  
Injuries  to  skeletal  muscle  are  associated  with  atrophy  of  muscle  fibers,  and  
excess  extracellular  matrix  accumulation,  called  fibrosis.  Regeneration  of  skeletal  
muscle  is  a  complex  process  and  involves  the  coordination  of  many  different  cell  types  
directing  many  processes  within  skeletal  muscle  (24).  For  minor  injuries,  muscle  can  
heal  without  any  intervention,  and  will  usually  recover  to  full  function.  However,  more  
severe  chronic  injuries  and  diseases  to  skeletal  muscle  result  in  the  progressive  loss  in  
muscle  size  and  function,  and  do  not  heal  over  time.  In  addition  to  severe  muscle  
atrophy  and  fibrosis,  some  chronic  injuries  also  cause  infiltration  of  lipid  within  and  
between  skeletal  muscle  fibers,  and  disrupt  the  ability  of  the  muscle  to  function  normally  
(13,  14,  20).  The  pathological  accumulation  of  lipid,  along  with  muscle  atrophy  and  
fibrosis,  is  referred  to  as  myosteatosis.  This  phenomenon  is  not  new,  as  myosteatosis  
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was  first  recorded  in  1852  in  the  first  paper  to  describe  Duchenne  muscular  dystrophy  
(35).  Since  then,  advances  in  the  detection  lipid  infiltration  in  various  muscle  wasting  
injuries  and  diseases  have  been  made,  yet  the  cellular  and  molecular  etiology  of  
myosteatosis  remains  poorly  understood.      
In  a  healthy  individual,  lipid  accounts  for  approximately  0.5%  of  the  volume  of  
skeletal  muscle,  and  can  increase  up  to  7  fold  in  obese  individuals  (43)  and  increase  
similarly  in  athletes  (16).  In  extreme  cases  of  myosteatosis,  the  amount  of  lipid  can  
exceed  greater  than  50%  of  muscle  tissue  volume  (17).  A  muscle  cell  can  deal  with  
lipids  in  two  fundamental  ways,  either  utilize  fatty  acids  for  energy  production,  or  store  
them  as  triglycerides.  Lipids  are  typically  stored  in  skeletal  muscle  in  the  form  of  tiny  
triglyceride-­rich  puncta  within  skeletal  muscle  fibers,  often  in  close  proximity  to  
mitochondria  (16,  42).  Fatty  acids  cleaved  from  intracellular  lipid  droplets  can  be  utilized  
in  mitochondria  for  energy  production  through  beta-­oxidation  and  subsequent  ATP  
generation  in  the  electron  transport  chain  (44).  For  years,  two  distinct  populations  of  
mitochondria  were  thought  to  exist  in  skeletal  muscle:  intermyofibrillar,  which  exist  
between  myofibrils,  and  subsarcolemmal  mitochondria,  located  in  the  space  between  
myofibrils  and  the  plasma  membrane  (7,  12,  26).  Intermyofibrillar  mitochondria  have  
higher  respiratory  chain  complex  activity  (12)  and  are  thought  to  be  more  specialized  for  
the  production  of  energy  for  use  in  contracting  myofibrils  compared  to  subsarcolemmal  
mitochondria  (7).  More  recently,  mitochondria  have  been  shown  to  exist  in  a  larger  
network,  which  allows  for  a  cell-­wide  coupling  of  energy  and  membrane  potential  (15,  
36).  Instead  of  distinct  mitochondrial  populations,  a  dense  matrix  of  mitochondria  within  
the  myofibrils  called  I-­band  segments  extend  to  the  periphery  of  the  cell,  creating  
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peripheral  mitochondrial  segments  (36).  These  3-­dimensionally  connected  segments  
allow  for  a  mitochondrial  reticulum  to  exist  and  form  a  strong  electrical  coupling  between  
these  different  segments  and  across  the  muscle  cell  (3,  36).    
It  is  not  known  what  functional  consequences  are  directly  caused  by  excess  lipid  
accumulation  in  skeletal  muscle.  There  is  a  strong  negative  correlation  between  lipid  
infiltration  and  muscle  force  production  (13),  and  excess  lipid  in  other  disorders  such  as  
diabetes  and  cancer  can  result  in  increased  inflammation  (4,  44)  and  decreased  insulin  
signaling  (23,  44).  The  objective  of  this  study  was  to  evaluate  the  cellular  and  molecular  
pathways  that  are  involved  in  the  progression  of  myosteatosis  in  a  rat  model  of  rotator  
cuff  injury.  The  rotator  cuff  develops  substantial  myosteatosis  following  tear,  and  the  
condition  worsens  with  time  (14,  19).  Using  a  variety  of  omics  techniques,  including  
transcriptomics,  shotgun  lipidomics,  metabolomics,  and  proteomics,  we  assessed  
pathways  that  were  enriched  with  myosteatosis  using  bioinformatics  techniques.  We  
used  these  techniques  to  test  the  hypothesis  that  myosteatosis  arises  due  to  increased  
lipid  synthesis  genes  early  following  injury  and  sustained  lipid  accumulation  leads  to  
chronic  inflammation.    
METHODS  
   Animals.  This  study  was  approved  by  the  University  of  Michigan  IACUC.  Forty  
adult  male  Sprague  Dawley  rats  were  used  in  this  study  (N=10  per  group).  Bilateral  
supraspinatus  tears  were  administered  as  previously  described  (8),  with  a  slight  
modification.  Briefly,  a  deltoid-­splitting  transacromial  approach  was  used  to  expose  the  
supraspinatus  tendon,  and  a  tenectomy  was  performed,  removing  the  tendon  from  its  
footprint  on  the  humerus.  Following  tenectomy,  the  suprascapular  nerve  was  located,  
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and  approximately  a  3-­4mm  piece  of  the  nerve  was  removed,  creating  a  nerve  injury.  
The  deltoid  muscle  and  skin  were  closed  and  the  animals  were  allowed  to  recover  in  
their  cages.  After  a  period  of  either  10,  30,  or  60  days,  supraspinatus  muscles  were  
harvested,  weighed,  and  prepared  for  either  histology,  single  fiber  contractility,  
mitochondrial  enzyme  activity  measures,  or  minced  and  snap  frozen  in  25-­50mg  
aliquots  for  biochemical  measures.    
RNA  isolation  and  RNA  Sequencing  (RNASeq).  Snap  frozen  aliquots  of  muscle  
tissue  was  homogenized  in  QIAzol  (Qiagen,  Valencia,  CA)  and  isolated  using  a  micro  
RNeasy  kit  (Qiagen).  RNA  concentration  was  determined  using  a  NanoDrop  2000  
(Thermo  Fisher  Scientific,  Waltham,  MA).  For  each  sample,  250ng  total  RNA  was  
delivered  to  the  University  of  Michigan  Sequencing  Core  for  RNA  sequencing.  Sample  
concentrations  were  normalized  and  cDNA  pools  were  created  for  each  sample,  and  
then  subsequently  tagged  with  a  barcoded  oligo  adapter  to  allow  for  sample  specific  
resolution.  Sequencing  was  carried  out  using  an  Illumina-­HiSeq  platform  (Illumina,  San  
Diego,  CA)  and  50bp  single  end  reads.  Raw  RNASeq  data  was  quality  checked  using  
FastQC  v0.10.0  (Barbraham  Bioinformatics,  Cambridge,  UK),  and  alignment  to  the  
reference  genome  (rn5,  UCSC),  differential  expression,  and  post-­analysis  diagnostics  
were  carried  out  using  the  Tuxedo  Suite  software  package  (40).  Transcripts  were  
considered  differentially  expressed  based  on  q<0.05  and  fold  change≥1.5.    
Shotgun  lipidomics  and  metabolomics.  Aliquots  of  muscle  tissue  were  delivered  
to  the  University  of  Michigan  metabolomics  core  for  mass  spectrometry  based  shotgun  
lipidomics  and  metabolomics.  For  lipidomics,  lipids  were  extracted  from  samples  with  a  
solvent  mixture  consisting  of  2:2:2  (v/v/v)  methanol:dichloromethane:water  mixture  at  
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room  temperature  after  adding  internal  standard  mixture.  After  drying,  the  samples  were  
resuspended  in  a  solution  containing  1:5:85  (v/v/v)  acetonitrile:water:isopropanol  and  
10mM  ammonium  acetate.  Samples  were  then  subjected  to  liquid  chromatrography-­
mass  spectrometry  (LC-­MS),  and  MS  peaks  were  matched  in-­silico  with  LipidBlast  (25).  
Quantification  was  performed  by  Multiquant  software  (AB-­SCIEX,  Framingham,  MA).  
For  metabolomics,  metabolites  were  extracted  from  frozen  muscle  in  a  solvent  mixture  
containing  8:1:1  methanol:chloroform:water  (v/v/v).  Hydrophilic  interaction  
chromatography-­electropray  time  of  flight  MS  was  used  to  determine  polar  metabolites  
(28).  Reversed  phase  liquid  chromatography-­tandem  quadrupole  MS  was  used  to  
measure  acylcarnitines.  Other  metabolites  were  derivatized  and  analyzed  with  gas  
chromatography-­MS.  Quantification  of  metabolites  was  performed  using  Masshunter  
Quantitative  Analysis  software  (Agilent  Technologies,  Santa  Clara,  CA).    
Bioinformatics.  Expression  data  from  RNASeq  measurements  was  imported  into  
Ingenuity  Pathway  Analysis  (IPA)  software  (Qiagen)  to  determine  cellular  and  molecular  
pathways  involved  in  myosteatosis.  For  metabolomics  and  lipidomic  measures,  MS  
peak  data  was  imported  into  Metaboanalyst  (metaboanalyst.ca,  McGill  University,  
Ontario,  Canada)  for  data  normalization  and  statistical  analysis.  Heatmaps  were  
generated  in  Prism  6.0  (GraphPad  Software,  La  Jolla,  CA).    
Permeablized  muscle  fiber  contractility.  Distal  segments  of  supraspinatus  
muscles  were  prepared  for  single  fiber  contractility  as  described  (19,  37).  Ten  to  20  
fibers  per  muscle  were  used  for  experiments.    
Electron  Microscopy.  Portions  of  distal  supraspinatus  muscles  were  fixed  in  1%  
tannic  acid,  1%  glutaraldehyde  in  Sorenson’s  buffer,  followed  by  post-­fixation  in  2%  
   72  
osmium  tetroxide  (Electron  Microscopy  Sciences,  EMS,  Hatfield,  PA).  Samples  were  
then  dehydrated  using  a  graded  ethanol  series  and  embedded  in  EMBed  812  resin  
using  a  graded  resin  (EMS)  and  propylene  oxide  series.  One  micron  transverse  
sections  were  cut  with  a  diamond  knife  ultramicrotome,  and  imaged  using  a  JEOL  1400-­
plus  transmission  electron  microscope  with  a  high-­resolution  AMT  digital  camera  (JEOL  
USA,  Peabody,  MA).    
Hydroxyproline  content.  Hydroxyproline  was  measured  from  the  insoluble  fraction  
of  preparation  from  protein  isolation.  Pellets  were  dried  at  100ºC  overnight,  and  
hydroxyproline  was  determined  as  described  previously  (20).  
Mitochondrial  DNA  (mtDNA)  measurements.  Total  DNA  was  isolated  from  frozen  
aliquots  of  muscle  tissue  using  the  DNeasy  Blood  &  Tissue  Kit  (Qiagen).  DNA  was  
amplified  via  qPCR  with  custom  primers  for  mtDNA  
(Fwd:5’AGCTTAATCACAAAGCATCTGGCCT3’;;  Rev:5’  
TGTTGGTTGGTTGTAGGGCTAGGGT3’)  and  beta-­2-­microglobulin  (B2M)  genomic  
DNA  (gDNA,  Fwd:5’  GTGCTTGTCTCTCTGGCCGTCG3’;;  Rev:5’  
AACGCCCACTCCTTTCCCGAGA3’).  Using  known  standards  of  rat  DNA,  standard  
curves  were  generated  for  each  primer  set  to  determine  number  of  copies  of  either  
mtDNA  or  gDNA.  The  ratio  of  mtDNA/gDNA  was  calculated  per  sample  and  averaged  
across  groups.    
Mitochondrial  enzymatic  assays.  Fifty  milligrams  of  freshly  minced  supraspinatus  
tissue  was  isolated  and  placed  in  500μL  of  ice  cold  PBS  (Thermo  Fisher)  containing  
protease  inhibitor.  Samples  were  homogenized  and  then  100μL  of  10%  laurel  maltoside  
and  400μL  cold  PBS  with  protease  inhibitor  was  further  added.  Samples  were  incubated  
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on  ice  for  30min  and  then  centrifuged  at  12,000xg  for  20  min  at  4ºC.  Samples  were  
stored  at  -­80ºC  until  use.  On  the  day  of  measurement,  samples  were  thawed  on  ice,  
and  protein  concentration  was  determined  using  a  BCA  assay  (Thermo  Fisher).  
Colorimetric  enzymatic  assays  for  mitochondrial  complex  I,  II,  and  IV  were  performed  as  
per  the  protocol  acquired  from  the  manufacturer  (AbCam,  San  Francisco,  CA).  Sample  
concentration  was  optimized  per  assay  in  pilot  experiments,  and  equal  protein  was  
loaded  per  well.  Samples  were  measured  in  duplicate  in  a  BioTek  Epoch2  microplate  
spectrophotometer  (BioTek,  Winooski,  VT).  Optical  density  per  minute  (mOD/min)  was  
calculated  as  per  the  manufacturer  protocol.    
Protein  oxidation  measurements.  Protein  was  isolated  from  frozen  aliquots  of  
supraspinatus  tissue  and  treated  with  2,4-­dinitrophenylhydrazine  (Sigma-­Aldrich,  
Dorset,  United  Kingdom).  Glutathionylation  and  carbonylation  of  protein  was  measured  
as  previously  described  (31).  Blots  were  imaged  using  a  Chemidoc  (Bio-­Rad),  and  band  
densitometry  was  measured  using  ImageJ  (NIH).    
Western  blots.  Protein  was  isolated  from  frozen  aliquots  of  muscle  tissue  and  
placed  in  500μL  of  a  solution  containing  TPER  (Thermo  Fisher  Scientific,  Waltham,  MA)  
with  1%  NP-­40  and  1%  protease-­phosphatase  inhibitor.  Samples  were  homogenized,  
vortexed  at  4ºC  for  30  min,  then  centrifuged  at  12,000xg  for  15  min  at  4ºC.  The  
supernatant  was  collected  and  saved  at  -­80ºC  until  use.  The  pellets  were  saved  for  
hydroxyproline  assays.  Protein  concentration  was  determined  with  a  BCA  assay  
(Thermo  Fisher).  Twenty  micrograms  of  protein  were  loaded  into  6-­12%  polyacrylamide  
gels,  and  subjected  to  electrophoretic  separation.  Proteins  were  transferred  onto  
nitrocellulose  membranes  (Bio-­Rad)  and  blocked  for  1h  in  5%  skim  milk.  Membranes  
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were  rinsed  and  incubated  overnight  in  rabbit  primary  antibodies  (Cell  Signaling,  
1:1000)  against  either  succinate  dehydrogenase-­A  (SDHA,  SDH,  D6J9M),  cytochrome  c  
oxidase  subunit  4  (COXIV,  3E11),  Phospho-­Insulin-­like  Growth  Factor-­1  Receptor  (P-­
IGF-­1R)  Tyr1135  (DA7A8),  Phospho-­p44/42  MAPK  (P-­Erk1/2)  Tyr202/204  (A13.14.4E),  
Protein  Kinase  B  (Akt)  Ser473  (D9E),  pan  Akt  (C67E7),  Phospho-­p70S6  Kinase  (P-­
p70S6K)  Thr389  (108D2),  P-­p70S6K  Thr421/Ser424,  pan  p70S6K  (49D7),  Phospho-­ribosomal  
protein  S6  (P-­rpS6)  Ser235/236  (D57.2.2E),  or  pan  rpS6  (5G10).  After  primary  antibody  
incubation,  membranes  were  rinsed  and  incubated  in  goat  anti  rabbit  horseradish  
peroxidase-­conjugated  secondary  antibodies  (Abcam).  Proteins  were  detected  using  
Clarity  Western  ECL  Substrate  (Bio-­Rad)  and  imaged  on  a  Chemidoc  (Bio-­Rad).  
Statistics.  Differences  between  groups  were  measured  using  One-­way  ANOVAs  
(α=0.05),  followed  by  Fisher’s  LSD  post  hoc  sorting  (α=0.05).  Analyses  were  performed  
using  Prism  6.0  (GraphPad).  Values  are  presented  as  mean+SD.  
RESULTS  
   Rotator  cuff  tear  resulted  in  a  decrease  in  supraspinatus  mass  that  reached  the  
lowest  point  at  30d  compared  to  uninjured  controls,  with  a  slight  increase  from  30d  to  
60d  (Figure  4.1A).  There  was  an  increase  in  transcripts  measured  by  RNASeq  related  
to  muscle  atrophy,  atrogin-­1  and  MuRF-­1  at  10d  compared  to  0d,  but  the  expression  of  
these  transcripts  returned  to  control  levels  at  30  and  60d  (Figure  4.1B).  Hydroxproline  
content  was  used  as  a  measure  of  collagen  accumulation,  and  compared  to  controls,  
fibrosis  did  not  accumulate  until  30d,  and  was  elevated  through  60d  (Figure  4.1C).  
There  was  an  increase  of  Col1a1  transcript  at  10d  compared  to  control,  and  an  increase  
in  Col3a1  expression  at  30d  compared  to  controls  (Figure  4.1C).  We  also  measured  via  
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RNASeq  the  expression  of  several  transcripts  related  to  inflammation.  Interleukin  (IL)-­1β  
(Il1b)  was  increased  at  10  and  30d  compared  to  control,  but  fell  to  control  levels  by  60d  
(Figure  4.1D).  IL-­12  (Il12)  was  increased  in  the  chronic  time  points  at  30  and  60d  
compared  to  controls  (Figure  4.1D).  IL-­23  (Il23)  and  interferon-­gamma  receptor  (IFNγ-­
R,  Ifngr)  were  both  increased  at  10d  and  30d  compared  to  controls,  then  returned  to  
control  levels  by  60d  (Figure  4.1D).  
   For  single  muscle  fiber  contractility,  there  was  a  decrease  in  CSA  compared  to  
control  at  all  time  points,  with  30d  having  the  lowest  CSA  among  groups  (Figure  4.2A).  
Similarly,  there  was  a  decrease  in  both  Fo  (Figure  4.2B)  and  sFo  (Figure  4.2C)  at  10d  
and  a  further  decrease  at  30d,  which  increased  slightly  at  60d  but  not  to  the  level  of  
controls.  Sarcomere  ultrastructure  was  disrupted  noticeably  at  all  time  points  compared  
to  control,  where  large  lipid  droplets  seemed  to  affect  sarcomere  alignment  and  
arrangement  (Figure  4.2D).  Qualitatively,  many  large  lipid  droplets  were  found  within  
mitochondria  at  10d  and  30d,  and  large  lipid  droplets  were  far  less  abundant  in  the  
intracellular  space  by  60d  (Figure  4.2D).  
   Shotgun  lipidomics  revealed  differences  in  many  different  lipid  species  across  
groups.  Cholesterol  ester  levels  increased  at  10d  and  30d  compared  to  0d,  but  fell  back  
to  control  levels  by  60d  (Figure  4.3A).  Monoacylglyceride  levels  stayed  relatively  stable  
across  groups,  with  slight  decreases  at  10d  and  60d  compared  to  0d  (Figure  4.3B).  
Diacylglyceride  levels  did  not  increase  until  30d  compared  to  controls,  and  slightly  
decreased  at  60d  compared  to  30d,  but  at  a  level  still  higher  than  10d  (Figure  4.3C).  
Triacylglyceride  (TAG)  was  the  most  abundant  lipid  measured  by  a  wide  margin,  and  
there  was  a  time-­dependent  increase  in  TAG  with  rotator  cuff  tear  (Figure  4.3D).  We  
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also  measured  the  accumulation  of  common  free  fatty  acid  species  and  there  was  an  
increase  in  palmitic  acid  (Palmitate)  and  stearic  acid  (Stearate)  at  30d  and  60d  
compared  to  control  and  10d  (Figure  4.3E),  and  an  increase  in  oleic  acid  (Oleate)  at  30d  
and  60d  compared  to  0d  (Figure  4.3E).  
   Transcripts  measured  in  RNASeq  datasets  were  uploaded  into  Ingenuity  
Pathway  Analysis  (IPA)  software  to  determine  pathways  that  were  involved  in  the  
progression  of  myosteatosis.  One  of  the  highest  scored  pathways  by  IPA  in  the  early  
phases  of  myosteatosis  was  mitochondrial  dysfunction,  and  in  the  later  time  points  
PKC-­theta  signaling  and  reactive  oxygen  species  generation  were  the  most  involved  
(Table  4.1).  Interestingly,  compared  to  0d,  the  very  lowest  scored  pathways  from  IPA  at  
10d  was  lipid  beta-­oxidation,  and  this  cellular  process  was  decreased  at  later  time  
points  as  well  (Table  4.2).  Additionally,  we  measured  the  counts  for  transcripts  in  
RNASeq  data  that  relate  to  lipid  synthesis,  breakdown,  and  utilization.  For  lipid  
synthesis,  diacylglycerol  acetyl  transferase  (DGAT)  1  was  largely  unchanged  until  a  
downregulation  at  60d  compared  to  all  other  time  points  (Figure  4.4A).  DGAT2  was  
decreased  from  0  and  10d  at  30  and  60d  (Figure  4.4A).  For  lipid  breakdown,  lipoprotein  
lipase  (LPL)  was  decreased  from  0d  at  30  and  60d,  and  hormone  sensitive  lipase  
(HSL),  was  unchanged  among  all  time  points  (Figure  4.4B).  Carnitine  palmitoyl  
transferase  (CPT)  I  was  increased  at  30d  compared  to  control  and  returned  to  control  
levels  at  60d  (Figure  4.4C).  CPT  II,  SDH,  and  COXIV  were  decreased  at  10d  compared  
to  control  (Figure  4.4C).  CPTII  was  also  decreased  from  control  at  60d,  and  SDH  
remained  decreased  through  the  remaining  time  points  (Figure  4.4C).  COXIV  returned  
to  control  levels  by  60d  (Figure  4.4C).  
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   Mass  spectrometry  metabolomics  were  used  to  assess  the  changes  in  
metabolites  from  beta-­oxidation.  Across  all  time  points,  there  was  a  decrease  in  all  long-­
chain  acyl  carnitine  levels  with  injury  (Figure  4.5A,B).  L-­carnitine  levels  were  also  
decreased  across  all  time  points  compared  to  0d  (Figure  4.5C).    
   Several  different  measures  of  protein  abundance  and  activity  were  used  to  
assess  mitochondrial  function.  There  was  no  change  in  either  mtDNA/gDNA  ratio  
(Figure  4.6A)  or  cardiolipin  levels  across  any  time  point  (Figure  4.6B).  There  was  
decrease  in  SDH  protein  levels  with  injury  compared  to  control  (Figure  4.6C),  but  no  
differences  in  COXIV  protein  abundance  (Figure  4.6D).  Electron  micrographs  revealed  
an  accumulation  of  peripheral  segment  mitochondria  in  all  injured  time  points  (Figure  
4.6E).  To  assess  mitochondrial  enzymatic  function,  we  used  various  mitochondrial  
enzyme  assays.  Complex  I  activity  was  decreased  from  control  at  10d,  but  increased  to  
control  levels  by  30d  and  60d  (Figure  4.6F).  Complex  II  activity  decreased  from  control  
at  10d,  but  increased  beyond  control  levels  at  30d  and  60d  (Figure  4.6G).  Complex  IV  
activity  also  decreased  at  10d  compared  to  0d,  and  activity  was  highest  at  60d  (Figure  
4.6H).    
To  measure  protein  oxidation,  we  measured  overall  carbonylation  and  
glutathionylation.  Carbonylated  proteins  were  not  different  across  groups  (Figure  4.7A),  
but  there  was  an  increase  in  glutathionylation  from  control  at  10d  and  30d,  which  
decreased  to  control  levels  by  60d  (Figure  4.7B).  Additionally,  while  there  was  no  
change  in  peroxiredoxin6  (Prdx6)  abundance  (Figure  4.7C),  there  was  a  dramatic  
increase  in  the  oxidated  form  of  Prdx6  at  60d  (Figure  4.7D).  
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   We  measured  various  components  of  the  insulin  like  growth  factor-­1  (IGF-­1)  
pathway  to  assess  the  changes  in  phosphorylation  in  key  proteins  and  kinases  along  
the  protein  synthesis  cascade.  There  was  a  decrease  in  P-­IGF-­1R  (Ser1135)  at  30d  and  
60d  compared  to  0d  (Figure  4.8A).  Similarly,  there  was  a  decrease  in  P-­Akt  (Ser473)  at  
60d,  but  not  at  30d  (p=0.08),  compared  to  controls,  but  no  change  in  total  Akt  across  
groups  (Figure  4.8B).  There  was  a  decrease  in  P-­Erk1/2  (Thr202/Tyr204)  across  all  time  
points  compared  to  0d  (Figure  4.8C).  No  change  was  observed  for  P-­p70S6K  (Thr389)  
between  groups,  but  a  decrease  across  all  injury  time  points  for  P-­p70S6K  (Thr421/Ser424)  
compared  to  0d  (Figure  4.8D).  Total  p70S6K  was  unchanged  until  a  slight  decrease  at  
60d  compared  to  10d  (Figure  4.8D).  Interestingly,  there  was  an  increase  in  P-­rpS6  
(Ser235/236)  at  10d  and  30d  compared  to  control  (Figure  4.8E).  There  was  a  
corresponding  increase  in  total  rpS6  at  30d  compared  to  control,  but  no  other  
differences  between  groups  (Figure  4.8E).      
DISCUSSION  
For  over  150  years,  myosteatosis  was  a  relatively  unstudied  phenomenon,  
despite  the  suggestion  of  a  limited  number  of  studies  that  pathological  lipid  
accumulation  with  myosteatosis  correlated  with  muscle  dysfunction  (13,  14).  The  aim  of  
this  study  was  to  identify  previously  unknown  mechanisms  that  explain  the  etiology  of  
myosteatosis  in  a  model  of  rotator  cuff  tears  in  rats.  The  results  from  this  study  indicate  
that  infiltrating  lipid  that  arises  in  myosteatosis  is  not  from  de  novo  lipogenesis,  but  
potentially  from  decreased  lipid  utilization  by  dysfunctional  mitochondria.  This  study  also  
indicates  that  myosteatosis  in  rotator  cuff  tears  is  a  result  from  at  least  two  distinct  
stages  of  injury.  The  first  of  which  is  an  acute  inflammatory  condition  marked  by  
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mitochondrial  dysfunction  and  intracellular  lipid  accumulation  by  10  days.  The  second  
phase,  which  occurs  by  30  days  post  injury  and  continues  through  60  days,  is  a  
chronically  inflamed  environment  under  active  remodeling  and  marked  by  extracellular  
lipid  accumulation,  oxidative  stress,  and  widespread  muscle  wasting.    
During  more  commonly  studied  cardiotoxin  or  lengthening  contraction-­based  
skeletal  muscle  injuries,  muscles  are  typically  fully  regenerated  within  30-­60  days  (6,  
11).  In  the  current  study,  myosteatosis  results  in  a  progressive  loss  of  muscle  function,  
sarcomere  disruption,  atrophy,  and  fibrosis  that  continues  through  60  days  following  
injury.  Lipid  levels  also  do  not  return  to  normal  over  time,  as  the  injury  is  marked  by  a  
dramatic  time-­dependent  increase  in  TAG  species  both  intracellularly  and  
extracellularly,  as  well  as  a  dramatic  increase  in  DAG  at  the  chronic  time  points.  Despite  
the  increase  in  TAG,  expression  of  genes  related  to  TAG  synthesis,  DGAT1/2,  were  
largely  unchanged  with  injury,  and  downregulated  at  time  points  that  correspond  to  the  
most  lipid  accumulation.  The  early  increase  in  lipid  can  be  found  intracellularly  within  
mitochondria,  which  appear  to  be  greatly  disrupted  structurally.  IPA  software  analysis  of  
RNASeq  data  predicted  that  beta-­oxidation  was  the  most  downregulated  cellular  
process,  and  it  is  conceivable  that  in  the  absence  of  increased  lipid  synthesis,  a  lack  of  
beta-­oxidation  in  mitochondria  can  lead  to  a  backup  of  lipid.  Shuttling  lipid  into  
mitochondria  for  beta-­oxidation  requires  the  conversion  of  long  fatty  acyl-­CoAs  into  fatty  
acyl-­carnitines  (22),  and  this  is  accomplished  through  the  action  of  carnitine  palmitoyl  
transferases  (CPTs)  and  L-­carnitine  (5).  Despite  the  dramatic  accumulation  of  lipid  
across  all  injured  time  points,  there  was  a  dramatic  decrease  in  long  chain  acyl-­
carnitines  and  L-­carnitine  measured  at  any  point  in  the  injury.  There  was  an  increase  in  
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CPTI  transcript  at  10  days,  but  a  decrease  in  CPTII  transcript  at  10  and  60  days  
compared  to  controls,  which  is  conceivable  given  the  decrease  in  long  chain  acyl-­
carnitines  for  transport  by  CPTII.    
There  is  debate  in  the  literature  as  to  the  best  measure  of  total  mitochondrial  
mass  (27,  34),  as  mitochondria  are  constantly  in  a  state  of  flux  and  connected  in  a  large  
network  (3).  By  two  measures,  mtDNA  content  or  cardiolipin  abundance,  there  was  no  
change  in  mitochondrial  mass.  These  would  likely  be  more  appropriate  measures  of  
mitochondrial  mass  than  abundance  of  mitochondrial  complex  proteins,  given  the  
deficiencies  in  oxidation  and  the  increase  in  oxidative  stress.  Complex  II  protein  levels,  
measured  by  SDH  abundance,  was  decreased  from  control  at  all  time  points,  and  at  
10d  could  explain  the  drop  in  complex  II  activity  at  that  time.  But  the  activity  of  complex  
II  increased  at  30  and  60  days,  times  where  oxidative  stress  was  highest  in  the  
glutathionylation  and  oxidized  Prdx6  assays,  respectively.  Similarly,  though  complex  IV  
protein  was  unchanged,  COXIV  transcript  was  increased  at  10  days,  and  complex  IV  
activity  was  decreased  at  10  days  and  increased  at  60  days  compared  to  controls.  
Combined,  a  decrease  in  complex  I,  II,  and  IV  and  a  decrease  in  long  chain  acyl-­
carnitines  could  explain  the  lipid  arising  within  mitochondria  at  the  10  day  time  point.  In  
the  absence  of  beta-­oxidation,  lipid  would  either  build  up  in  lipid  droplets,  in  
mitochondria,  be  exported  out  of  the  cell,  or  remain  as  intracellular  fatty  acids.  
Mitochondria  have  homeostatic  roles  outside  of  energy  homeostasis,  and  can  be  
reservoirs  for  the  proteolysis  of  misfolded  proteins  (38).  It  is  possible  that  in  this  
particular  model,  or  in  other  times  of  lipid  excess  and  muscle  injury,  mitochondria  can  
also  be  reservoirs  for  lipid.  Mitochondrial  oxidation  can  also  be  inhibited  by  excess  lipid  
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(1),  and  could  provide  a  mechanism  by  which  mitochondrial  dysfunction  actually  occurs  
from  an  initial  increase  in  lipid,  further  exacerbating  the  problem  of  lipid  excess.  In  either  
case,  the  more  proximal  mechanisms  by  which  mitochondrial  dysfunction  arises  in  this  
model  need  to  be  studied  further.  Overall,  it  is  clear  that  rotator  cuff  injury  results  in  
widespread  mitochondrial  dysfunction,  and  an  inability  to  oxidize  lipid,  leading  to  an  
early  increase  in  intracellular  lipid.    
In  the  more  chronic  time  points  in  this  injury  model,  there  are  also  several  other  
factors  that  can  lead  to  the  decrease  in  muscle  specific  force  generation  at  30  and  60  
days  post  injury.  Mitochondrial  dysfunction  continued,  as  oxidative  stress  was  highest  at  
the  chronic  time  points,  and  there  was  an  accumulation  of  peripheral  segment  
mitochondria.  In  the  two  mitochondrial  population  model,  the  peripheral,  or  
subsarcolemmal,  mitochondria  have  decreased  oxidative  capacity  compared  to  
mitochondria  in  the  myofibrillar  space  (7,  12,  26).  In  the  mitochondrial  reticulum  model,  
peripheral  segment  mitochondria  have  a  greater  abundance  of  proton  motive  proteins,  
whereas  the  intermyofibrillar  mitochondria  have  more  ATP  generating  proteins  for  use  
by  sarcomeres  (15,  36).  In  the  current  study,  the  abnormal  spherical  mitochondria  in  the  
peripheral  space  of  injured  muscles  at  30  and  60  days  post  injury  could  reflect  a  
mitochondrial  network  that  has  been  disrupted.  A  network  of  long  tube-­like  mitochondria  
that  undergoes  fission  results  in  an  accumulation  of  less  tubular  and  more  spherical  
mitochondria  at  the  edges  of  fission  (32).  Given  the  widespread  mitochondrial  
dysfunction  with  myosteatosis,  it  is  possible  that  the  conduction  of  energy  homeostasis  
is  lost  with  injury,  and  fission  events  could  explain  the  accumulation  of  mitochondria  in  
these  spaces,  however  this  warrants  further  study.  
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In  addition  to  continued  mitochondrial  dysfunction,  there  is  a  continued  increase  
in  lipid  at  the  30d  and  60d  time  points  compared  to  control  and  10d.  Not  only  does  TAG  
continue  to  dramatically  rise,  but  there  is  also  an  accumulation  of  non-­stable  lipid  
intermediates,  such  as  DAG,  palmitate,  stearate,  and  oleate.  Many  of  the  available  
studies  on  the  effect  of  these  intermediates  on  muscle  energy  homeostasis  falls  within  
the  diabetes  literature.  Lipid  excess  within  diabetes  results  in  the  intracellular  
accumulation  of  fatty  acids  like  palmitate,  which  instead  of  stored  as  TAG,  build  up  as  
DAG  and  other  intermediates,  which  can  activate  inflammatory  pathways  (44).  DAG  
accumulation  also  activates  a  member  of  the  novel  family  of  protein  kinase  Cs,  PKCθ  
(18).  In  diabetes,  PKCθ  activation  inhibits  insulin  stimulated  glucose  uptake  by  
disrupting  insulin  signaling  (47).  The  inhibition  of  the  insulin  pathway  by  the  activation  of  
PKCθ  links  obesity  to  insulin  resistance,  where  the  excess  in  lipid  drastically  reduces  
insulin  signaling  (23).  In  skeletal  muscle,  one  of  the  main  pathways  that  regulates  mass  
is  the  IGF-­1  pathway,  which  shares  many  of  the  same  kinases  and  signaling  proteins  as  
the  insulin  pathway  (21,  39).  In  the  current  study,  IPA  software  predicted  PKCθ  
signaling  as  an  enriched  pathway  at  30  and  60  days  post  injury,  and  there  was  a  distinct  
decrease  in  proximal  IGF-­1  signaling  in  the  chronic  stages  of  rotator  cuff  tear.  There  
was  a  decrease  in  Akt  phosphorylation  in  the  chronic  time  points,  where  DAG  and  
palmitate  were  most  abundant.  Additionally,  there  was  a  decrease  in  Erk1/2  
phosphorylation  across  all  injury  time  points,  and  a  decrease  in  the  Erk-­dependent  
phosphorylation  sites  (Thr421/Ser424)  on  p70S6K.  Interestingly,  the  mTOR  dependent  site  
on  p70S6K,  Thr389,  was  unchanged,  despite  a  trend  for  increased  phosphorylation  at  30d  
compared  to  control  (p=0.07).  Other  than  a  slight  difference  in  timing  for  
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phosphorylation  between  the  different  sites  with  exercise  (9,  30),  to  our  knowledge  no  
other  study  has  found  quite  a  divergence  in  the  two  sites.  Surprisingly,  there  was  an  
increase  in  P-­rpS6  at  10  and  30  days  post  injury.  This  could  be  indicative  of  active  
remodeling,  as  there  is  an  increase  in  transcripts  related  to  autophagy  in  the  chronic  
time  points  of  this  model  of  muscle  injury  (19).  Further  study  will  identify  whether  PKCθ  
is  required  for  the  changes  in  IGF-­1  signaling  in  myosteatosis.    
This  study  has  several  limitations.  Myosteatosis  is  not  limited  to  the  rotator  cuff  
muscle  group.  It  can  occur  in  hamstring  muscles  (41),  paraspinal  muscles  with  chronic  
back  pain  (2),  with  degenerative  diseases  like  Duchenne  muscular  dystrophy  (45)  and  
cancer  (10),  and  in  aging  (29).  Therefore,  there  may  be  some  differences  in  the  etiology  
of  myosteatosis  in  these  different  tissues  and  disease  states,  but  likely  these  findings  
may  help  identify  common  themes  for  the  development  of  myosteatosis  in  other  injuries  
and  diseases.  Additionally,  this  study  assessed  myosteatosis  in  a  model  of  combined  
tenectomy  and  neurectomy,  but  did  not  decipher  the  effects  of  each  individually.  
However,  we  chose  the  combined  approach  due  to  the  collective  mechanical  injury  and  
neurodegenerative  components  that  lead  to  myosteatosis  in  humans.  In  humans,  the  
wasting  of  skeletal  muscle  with  myosteatosis  does  not  improve  with  time  (13,  14,  33),  
but  in  rats  there  seems  to  be  a  small  increase  in  specific  force  generation  around  60d  
following  injury  compared  to  30d.  It  is  not  clear  whether  this  will  continue  to  improve,  but  
based  on  sustained  oxidative  stress,  inflammation,  and  sarcomere  disruption  even  at  
60d,  it  is  unlikely  that  the  muscle  will  be  able  to  fully  regenerate  even  in  the  rat  model.  
Despite  these  limitations,  this  study  provided  substantial  insight  into  the  mechanisms  of  
myosteatosis  over  the  course  of  a  chronic  degenerative  injury.    
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Myosteatosis  is  a  degenerative  disorder  that  results  in  chronic  muscle  wasting,  
and  can  get  worse  with  time.  The  early  phases  of  myosteatosis  arise  due  to  a  decrease  
in  mitochondrial  function,  where  lipid  droplets  form  in  myofibers  and  within  mitochondria,  
and  muscles  have  a  widespread  decrease  in  lipid  beta-­oxidation.  Shuttling  lipid  into  
droplets  may  initially  serve  as  a  protective  effect  for  the  cell,  as  this  would  prevent  the  
cell  from  high  concentrations  of  reactive  fatty  acid  molecules  and  lipid  intermediates  (46,  
48).  However,  over  time,  decreased  beta-­oxidation  would  render  the  muscle  cell  
incapable  of  decreasing  lipid  levels,  and  sustained  damaged  mitochondria  results  in  
increased  oxidative  stress.  This  further  expansion  of  oxidative  stress,  lipid,  and  
inflammation  results  in  dramatic  atrophy  of  the  muscle  fiber,  and  a  chronic  degenerative  
condition.  Combined,  this  results  in  a  temporal  decrease  in  muscle  function,  which  does  
not  return  at  time  points  where  muscle  function  is  restored  in  non-­lipid  accumulating  
injuries  (6,  11).    
In  order  to  develop  therapies  for  the  treatment  of  muscle  wasting  in  
myosteatosis,  a  better  understanding  of  the  cellular  and  molecular  mechanisms  behind  
the  accumulation  of  lipid  accumulation  and  muscle  function  is  required.  The  results  of  
this  study  provide  the  framework  for  the  development  of  therapies  to  increase  muscle  
function  and  regeneration  in  patients  with  myosteatosis.  With  further  study  of  the  
mechanism  and  translatability  in  humans,  methods  that  target  IGF-­1  signaling  would  be  
an  attractive  therapeutic  direction  that  could  help  not  only  rotator  cuff  tears,  but  a  much  
wider  range  of  muscle  injuries  and  diseases  that  affect  millions  of  people  in  the  world.  
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Figure  4.1.  Measures  of  atrophy,  fibrosis,  and  inflammation  over  time  following  rotator  
cuff  tear.  (A)  Supraspinatus  (SSP)  mass  after  isolation  from  torn  rotator  cuff  muscles.  
(B)  Expression  of  transcripts  measured  by  RNA  Sequencing  related  to  muscle  
atrophy.  (C)  Hydroxyproline  content,  a  commonly  used  measure  of  collagen  content  
or  fibrosis,  following  rotator  cuff  tear,  and  expression  of  type  I  and  III  collagen  
transcripts  measured  by  RNA  Sequencing.  (D)  Expression  of  transcripts  measured  by  
RNA  Sequencing  related  to  inflammation.  Data  are  presented  mean+SD.  a,  Different  
from  0d;;  b,  Different  from  10d;;  c,  Different  from  30d  (P  <0.05).  
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Figure  4.2.  Changes  in  single  fiber  contractility  and  sarcomere  ultrastructure  over  
time  following  rotator  cuff  tear.  (A)  Cross  sectional  area  (CSA),  (B)  maximum  
isometric  force,  and  (C)  specific  force  of  permeablized  muscle  fibers  from  
supraspinaus  muscles  following  tear.  Data  are  presented  mean+SD.  a,  Different  from  
0d;;  b,  Different  from  10d;;  c,  Different  from  30d  (P  <0.05).  (D)  Representative  images  
of  sarcomere  ultrastructure  in  supraspinatus  muscles  following  rotator  cuff  tear.  White  
arrows  indicate  lipid-­laden  mitochondria.  Scale  bar  is  2μm  
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Figure  4.3.  Changes  in  lipid  species  over  time  following  rotator  cuff  tear.  Sum  of  peak  
intensities  of  major  lipid  classes  including  (A)  cholesterol  ester,  (B)  monoacylglyceride  
(MAG),  (C)  diacylglyceride  (DAG),  and  (D)  triacylglyceride  (TAG)  measured  by  
shotgun  lipidomics.  Data  are  presented  mean+SD.  a,  Different  from  0d;;  b,  Different  
from  10d;;  c,  Different  from  30d  (P  <0.05).  (E)  Heatmap  of  changes  in  fatty  acid  
species  measured  by  metabolomic  analyses.  a,  Different  from  0d;;  b,  Different  from  
10d  (P  <0.05).  
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Figure  4.4.  Expression  of  transcripts  measured  by  RNASeq  at  each  time  point  
following  rotator  cuff  tear.  Transcripts  that  correspond  to  (A)  lipid  synthesis,  (B)  
lipolysis,  and  (C)  lipid  utilization.  Data  are  presented  mean+SD.  a,  Different  from  0d;;  
b,  Different  from  10d;;  c,  Different  from  30d  (P  <0.05).    
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Figure  4.5.  Decreases  in  acyl-­carnitine  species  following  rotator  cuff  tear.  (A)  
Heatmap  of  acyl-­carnitine  species  in  torn  rotator  cuff  muscles.  (B)  Quantification  of  
mass  spec  peak  intensity  values  for  (B)  all  long  chain  (C>5)  acyl-­carnitines,  and  (C)  L-­
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Figure  4.6.  Mitochondrial  levels,  localization,  and  enzyme  activity  over  time  following  
rotator  cuff  tear.  (A)  Mitochondrial  DNA:genomic  DNA  ratio  using  specific  primers  
against  mtDNA  and  genomic  beta-­2-­microglobulin  and  (B)  Cardiolipin  levels  as  
measures  of  mitochondrial  mass  in  torn  rotator  cuff  muscles.  (C)  Western  blot  
analysis  of  SDH  or  (D)  COXIV  proteins  from  supraspinatus  muscle  homogenates.  (E)  
Representative  EM  images  of  subsarcolemmal  mitochondria  in  supraspinatus  
muscles  following  rotator  cuff  tear.  White  arrows  indicate  accumulation  of  peripheral  
space  mitochondria.  Scale  bar  is  2μm.  Mitochondrial  enzyme  assay  for  (F)  complex  I,  
(G)  complex  II,  and  (H)  complex  III.  For  A-­D  and  F-­H,  Data  are  presented  mean+SD.  
a,  Different  from  0d;;  b,  Different  from  10d;;  c,  Different  from  30d  (P  <0.05).    
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Figure  4.7.  Markers  of  oxidative  stress  over  time  following  rotator  cuff  tear.  Protein  
(A)  carbonylation  and  (B)  glutathionylation,  (C)  Peroxiredoxin  6  protein  content  and  
(D)  oxidized  peroxiredoxin  6  accumulation  in  supraspinatus  muscles  following  rotator  
cuff  tear.  Mitochondrial  enzyme  assay  for  (A)  complex  I,  (B)  complex  II,  and  (C)  
complex  III.  Data  are  presented  mean+SD.  a,  Different  from  0d;;  b,  Different  from  10d;;  
c,  Different  from  30d  (P  <0.05).  
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Figure  4.8.  Decreased  proximal  IGF-­1  signaling  after  rotator  cuff  tear.  Western  blot  
quantification  of  (A)  phospho-­IGF-­1  receptor,  (B)  phospho-­Akt  (Ser473),  and  total  Akt  
abundance,  (C)  phospho-­Erk1/2  (Thr202/Tyr204),  (D)  phospho-­p70S6K  (Thr389  and  
Thr421/Ser424)  and  total  p70S6K  abundance,  and  (E)  phospho-­ribosomal  protein  S6  
and  total  rpS6  abundance.    Data  are  presented  mean+SD.  a,  Different  from  0d;;  b,  
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Table  4.1.  IPA  output  of  canonical  pathways  in  torn  rotator  cuff  muscles  
compared  to  control  muscles.  P-­values  indicate  test  against  0d.  
Time  Point   Canonical  Pathway   p-­value  
10d   Mitochondrial  Dysfunction   2.21E-­25  
   Oxidative  Stress  Response   1.26E-­14  
30d   PKC-­theta  Signaling   1.58E-­13  
   Macrophage  Activation   6.31E-­19  
60d   Macrophage  Activation   7.94E-­15  
   PKC-­theta  Signaling   3.10E-­10  
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Table  4.2.  IPA  output  of  cellular  processes  and  predicted  pathway  activation  
state  in  torn  rotator  cuff  muscles  compared  to  control  muscles.  P-­values  indicate  test  
against  0d.  
Cellular  Process   Time  Point   Predicted  Activation  State   p-­value  
Oxidation  of  Lipid   10d   Decreased   6.64E-­08  
   30d   Decreased   1.78E-­08  
   60d   Decreased   2.72E-­07  
Beta-­Oxidation  of  Fatty  Acid   10d   Decreased   1.21E-­07  
   30d   Decreased   1.90E-­08  
   60d   N/A   NS  
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   The  purpose  of  this  dissertation  was  to  better  understand  the  basic  biology  of  
tendon  growth  in  adulthood,  as  well  as  identify  mechanisms  that  lead  to  muscle  
dysfunction  following  rotator  cuff.  For  tendon,  the  overall  lack  of  knowledge  in  basic  
tendon  biology  restricted  our  ability  to  understand  the  molecular  changes  in  tendon  
during  injury.  For  muscle,  the  etiology  of  myosteatosis  and  consequences  on  muscle  
function  was  unknown,  preventing  the  development  of  targeted  strategies  to  ameliorate  
the  disorder.  The  studies  in  this  dissertation  filled  in  considerable  gaps  in  the  
understanding  of  basic  tendon  biology,  and  the  progression  of  skeletal  muscle  
myosteatosis.  Additionally,  this  body  of  work  established  several  new  directions  for  
future  research  that  not  only  apply  to  rotator  cuff  injuries  and  tendinopathies,  but  a  wide  
variety  of  musculoskeletal  disorders.    
FINDINGS  AND  FUTURE  DIRECTIONS-­  TENDON  
   Until  the  last  decade,  studying  adult  tendon  biology  was  extremely  challenging  
due  to  the  lack  of  tendon  markers  use  for  study.  The  approach  taken  by  our  lab  was  to  
identify  markers  that  were  important  for  tendon  development  in  utero,  and  study  these  
markers  in  adult  tendon.  The  basic  helix-­loop-­helix  transcription  factor,  scleraxis,  offered  
an  attractive  target  due  to  its  requirement  for  limb  tendon  development  and  it  was  the  
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earliest  detectible  tendon  marker  available  (8).  Early  studies  in  our  lab  showed  that  
scleraxis  expression  markedly  decreased  within  tendon  during  adulthood  compared  to  
adolescent  and  young  mice.  However,  during  physiological  loading,  scleraxis  
expression  was  dramatically  increased  in  the  outermost  region  of  the  tendon,  called  the  
epitenon  (13).  There  was  a  correlation  between  scleraxis  expression  and  increased  
tendon  CSA,  but  it  was  not  known  if  scleraxis  was  required  for  tendon  adaptation  in  
adults.  The  findings  of  this  dissertation  offered  substantial  insight  into  the  
mechanobiology  of  adult  tendon,  using  an  established  model  of  skeletal  muscle  
hypertrophy,  which  also  substantially  increases  tendon  size.    
   The  studies  in  Chapter  II  found  that  following  synergist  ablation,  tendon  grows  by  
the  formation  of  an  immature  tendon  matrix,  called  a  neotendon,  from  the  epitenon  
outwards,  similar  to  the  rings  of  a  tree.  Within  the  neotendon  were  an  abundance  of  
scleraxis+  cells,  many  of  which  were  proliferative.  This  was  associated  with  increased  
scleraxis  and  type  I  collagen  expression.  Despite  the  load  applied,  the  cells  within  the  
original  tendon  matrix  did  not  re-­enter  the  cell  cycle,  and  the  original  tendon  area  did  not  
change.  Other  lab  groups  posited  that  tendon  contained  different  populations  of  cells:  
tenoblasts,  which  are  proliferative  and  decreased  with  age,  and  tenocytes,  which  are  
terminally  withdrawn  from  the  cell  cycle,  but  participated  in  ECM  remodeling  and  
maintenance  (9,  16).  The  studies  in  Chapter  II  offered  in  vivo  evidence  for  multiple  
populations  of  cells  distinguished  by  their  proliferative  capacity.  Increased  scleraxis  
expression  in  these  proliferative  cells  also  showed  that  scleraxis  likely  had  a  central  role  
in  the  growth  and  adaptation  of  tendon  to  mechanical  loading.  
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To  assess  whether  scleraxis  was  required  for  tendon  adaptation,  we  utilized  a  
line  of  transgenic  mice  that  allowed  for  the  conditional  inactivation  of  scleraxis  in  
Chapter  III.  After  administering  tamoxifen  to  knock-­out  scleraxis,  following  synergist  
ablation,  tendons  from  transgenic  mice  displayed  dramatically  decreased  growth  due  to  
a  blunted  neotendon  compared  to  controls.  The  expression  of  several  matrix-­related  
genes  was  decreased  in  scleraxis  mutant  mice,  and  electron  micrographs  revealed  
aberrant  collagen  fibril  alignment  in  mutant  animals  compared  to  controls.  The  most  
interesting  finding  was  the  accumulation  of  CD146+  mesenchymal  stem  cells  in  the  
neotendon  of  mutant  animals.  The  expression  of  tenomodulin,  which  is  to  date  the  best  
marker  for  mature  tendon  fibroblasts,  was  decreased  in  mutant  animals,  suggesting  a  
failure  in  proper  tenogenic  differentiation.  These  data  provided,  for  the  first  time,  insight  
into  the  role  of  scleraxis  in  the  differentiation  of  adult  tendon  stem  cells.  These  data  
indicate  that  scleraxis  may  be  an  important  member  of  the  tenogenic  program,  which  
starts  from  a  CD146+  stem  cell,  differentiating  into  a  proliferative,  scleraxis+  fibroblast,  
then  losing  scleraxis  expression,  increasing  tenomodulin  expression,  and  becoming  a  
differentiated  tenocyte.    
   The  studies  in  this  dissertation  provided  substantial  insight  into  scleraxis  biology  
in  the  adult  tendon,  but  more  research  is  needed.  Future  studies  will  further  expand  the  
role  of  scleraxis  in  adult  tendon  biology,  and  the  differentiation  of  tendon  progenitors.  
We  are  currently  examining  the  role  of  scleraxis  in  the  differentiation  of  CD146+  cells  in  
vitro,  by  separating  CD146+  cells  from  tail  tendons,  and  plating  these  cells  in  a  3D  
matrix  of  type  I  collagen.  After  time  in  culture,  these  cells  temporally  express  scleraxis,  
and  tenomodulin  (Figure  1).  While  preliminary  with  only  an  N  of  2,  this  protocol  shows  
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tremendous  promise  in  studying  the  tenogenic  capacity  of  CD146+  cells  in  vitro.  We  
plan  on  isolating  CD146+  cells  from  Scxflox/flox:R26CreERT2/CreERT2  (Scx∆/∆)  mice  and  
repeating  this  study  with  the  addition  of  4HT  in  culture,  to  assess  whether  scleraxis  is  
required  for  the  tenogenic  capacity  of  these  cells.  Further,  we  are  underway  in  creating  
CD146CreERT2  mice,  which  we  can  cross  to  the  available  Rosa26Ai9  mice,  that  contain  a  
conditional  activation  cassette  for  the  fluorescent  protein,  tdTomato.  This  new  mouse  
would  allow  us  to  lineage  trace  CD146  cells  through  the  process  of  neotendon  formation  
during  plantaris  overload,  and  determine  if  indeed  that  this  population  is  the  tendon  
progenitor  cell  pool.  Additionally,  crossing  CD146CreERT2  mice  to  Rosa26DTA  mice  would  
allow  for  the  ablation  of  CD146  cells  to  see  if  they  are  required  for  the  expansion  in  
neotendon  following  plantaris  overload.  The  Rosa26DTA  mouse  expresses  a  modified  
form  of  the  diphtheria  toxin  receptor  (2),  and  after  the  addition  of  diphtheria  toxin  can  kill  
off  only  cells  that  express  the  receptor,  in  this  case  CD146+  cells.  Another  important  set  
of  experiments  would  be  to  isolate  tendon  progenitors  and  perform  experiments  to  
identify  the  upstream  regulators  of  scleraxis.  We  can  identify  potential  upstream  
transcription  factors  in  silico  using  the  scleraxis  promoter,  and  knock  out  top  candidates  
in  a  series  of  in  vitro  experiments.  The  factor  or  factors  that  lead  to  a  loss  in  scleraxis  
expression  would  be  strong  candidates  for  the  upstream  regulator  of  scleraxis,  and  
could  be  overexpressed  in  other  mesenchymal  cell  populations  to  determine  if  it  is  a  
master  regulator  of  the  tenogenic  cell  fate.    
   There  is  also  evidence  that  scleraxis  may  be  an  attractive  therapeutic  target  for  
the  treatment  of  tendinopathies.  Studies  in  our  lab  using  human  subjects  have  also  
identified  that  scleraxis  may  be  important  for  normal  tendon  homeostasis,  and  loss  of  
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scleraxis  could  lead  to  painful  tendinopathies.  We  obtained  biopsies  from  the  biceps  
tendon  of  patients  during  rotator  cuff  surgery.  The  biceps  are  not  part  of  the  rotator  cuff,  
and  served  as  a  control  for  tendon  tissue.  However,  some  of  the  biceps  tendons  of  
patients  displayed  tendinosis  from  pre-­operative  imaging.  Interestingly,  but  perhaps  not  
surprisingly  given  the  studies  outlined  in  this  dissertation,  the  epitenon  of  these  
tendinopathic  biopsies  displayed  a  complete  lack  of  scleraxis  compared  to  healthy  
tendon  biopsies  (Figure  2).    Therefore,  scleraxis  may  also  be  important  in  the  proper  
growth  and  maintenance  of  adult  tendon  in  humans,  and  could  potentially  be  re-­
administered  into  tendinopathic  tendons  as  a  therapy  for  these  painful  conditions.    
FINDINGS  AND  FUTURE  DIRECTIONS-­  SKELETAL  MUSCLE  
   Most  of  the  literature  on  rotator  cuff  myosteatosis  relies  on  a  recording  system  for  
the  severity  of  lipid  infiltration  known  as  Goutallier  scoring  (6).  The  scale  ranges  from  0,  
or  no  lipid,  to  4,  indicating  severely  more  lipid  than  muscle.  Countless  studies  use  this  
system  to  grade  the  severity  of  rotator  cuff  injuries  and  identify  very  strong  negative  
correlations  between  the  severity  of  lipid  and  muscle  function  (4,  5).  Despite  the  
importance  of  muscle  function  to  regeneration  and  recovery  from  injury,  there  were  very  
few  studies  that  actually  tested  what  the  molecular  consequences  of  myosteatosis  were.  
Other  than  in  rotator  cuff  injuries,  myosteatosis  can  occur  following  injury  to  hamstring  
muscles  (17),  paraspinal  muscles  (1),  with  diseases  like  Duchenne  muscular  dystrophy  
(14,  18)  and  cancer  (3),  and  in  aging  (12).  Therefore,  understanding  the  mechanisms  by  
which  lipid  infiltration  leads  to  muscle  wasting  could  have  an  effect  on  a  much  larger  
body  of  musculoskeletal  diseases,  not  just  the  rotator  cuff.  Identifying  how  lipid  arises,  
and  the  consequences  of  ectopic  lipid  on  muscle  function,  protein  homeostasis,  and  
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metabolism,  will  be  useful  in  the  development  of  therapies  to  reduce  myosteatosis  in  
patients.  Additionally,  it  is  still  not  known  why  the  rotator  cuff  exhibits  such  a  high  
degree  of  myosteatosis  compared  to  other  more  commonly  studied  muscle  injury  
models,  and  this  question  may  require  a  substantial  amount  of  research  to  address.
   Studies  in  Chapter  IV  aimed  to  assess  the  molecular  mechanisms  of  lipid  
infiltration  in  skeletal  muscle  during  myosteatosis.  Using  large  scale  omics  approaches,  
we  identified  several  new  mechanisms  by  which  lipid  accumulates  and  affects  muscle  
function  and  metabolism.  Using  RNA  Sequencing  (RNASeq)  and  bioinformatics,  we  
identified  mitochondrial  dysfunction  as  a  highly-­enriched  pathway,  and  interestingly,  
despite  the  massive  increase  in  lipid  with  injury,  lipid  oxidation  was  predicted  by  
analysis  software  to  be  the  most  decreased  pathway  with  injury.  We  assessed  several  
measures  of  mitochondrial  content,  localization,  and  function  and  determined  that  
myosteatosis  conferred  a  lack  of  beta-­oxidation,  an  increase  in  oxidative  stress,  and  an  
accumulation  of  mitochondria  in  the  peripheral  space  of  muscle  fibers.  There  was  a  
decrease  in  long-­chain  acyl  carnitines,  which  are  required  for  the  import  of  lipid  into  
mitochondria  for  beta-­oxidation,  yet  electron  micrographs  showed  that  early  after  injury,  
many  lipid  droplets  accumulated  inside  mitochondria.  Recent  studies  have  shown  that  
mitochondria  can  be  reservoirs  for  misfolded  protein  in  yeast  with  heat  shock  protein  
dysfunction  (15),  so  it  is  conceivable  that  mitochondria  can  perform  similar  functions  
with  lipid  during  myosteatosis.  An  accumulation  of  lipid  in  mitochondria  as  a  scavenging  
mechanism  could  lead  to  an  inability  to  oxidize  them,  exacerbating  the  accumulation  of  
lipid  further.  Future  studies  will  identify  whether  indeed  this  mechanism  exists  in  
mammalian  cells,  by  knocking  out  heat  shock  proteins  and  measuring  mitochondrial  
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lipid  accumulation.  Additionally,  as  mice  can  also  be  used  to  study  rotator  cuff  
myosteatosis  (11),  we  can  use  transgenic  mice  that  overexpress  heat  shock  proteins  
and  measure  lipid  accumulation  in  mitochondria  in  the  early  days  following  rotator  cuff  
tear.  This  would  provide  substantial  insight  into  whether  lipid  accumulation  is  a  cause  or  
consequence  of  mitochondrial  dysfunction.  To  test  this  in  a  rat  model,  dysfunctional  
mitochondria  can  be  isolated  from  torn  rotator  cuff  muscles  and  injected  into  healthy  
rotator  cuff.  This  would  also  identify  if  dysfunctional  mitochondria  were  sufficient  for  the  
accumulation  of  lipid  in  a  rat  model.    
The  studies  in  Chapter  IV  also  provided  important  insight  into  the  long-­term  
repercussions  of  lipid  accumulation.  Bioinformatics  analysis  identified  protein  kinase  C-­
theta  (PKCθ)  signaling  as  an  enriched  pathway  in  the  chronic  stages  of  myosteatosis.  
Not  much  is  known  about  this  pathway  in  the  context  of  skeletal  muscle  myosteatosis,  
but  several  studies  have  studied  PKCθ  signaling  in  skeletal  muscle  with  obesity  in  type  
II  diabetes.  During  lipid  excess  with  diabetes,  lipid  intermediates  build  up  within  the  
muscle  cell,  activating  PKCθ,  which  inhibits  the  insulin  pathway  (19).  The  insulin  like  
growth  factor-­1  (IGF-­1)  pathway  shares  many  of  the  same  members  of  the  signaling  
cascade  as  insulin,  and  the  IGF-­1  pathway  is  one  of  the  main  determinants  of  skeletal  
muscle  mass  (7).  Therefore,  it  is  possible  that  excess  lipid  in  myosteatosis  also  
activates  PKCθ  and  leads  to  a  decrease  in  IGF-­1  signaling,  further  causing  muscle  
weakness  and  atrophy.  Indeed,  components  of  IGF-­1  signaling  were  reduced  with  
injury,  and  future  studies  can  address  this  further.  Using  primary  rat  myotubes,  we  plan  
to  test  the  impact  of  excess  lipid  on  PKCθ  signaling  and  muscle  atrophy.  After  the  
addition  IGF-­1  to  cells,  we  can  measure  the  effect  of  free  fatty  acids  on  IGF-­1  signaling  
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components  and  myotube  size.  Additionally,  we  will  use  inhibitors  of  PKCθ  to  identify  if  
PKCθ  is  required  for  changes  in  lipid  induced  muscle  atrophy  and  IGF-­1  signaling.  This  
would  provide  a  much  greater  understanding  of  the  mechanisms  by  which  sustained  
ectopic  lipid  in  chronic  rotator  cuff  tears  leads  to  deficits  in  muscle  function.    
Clinically,  the  studies  outlined  here  may  provide  several  avenues  for  therapies  for  
myosteatosis.  Most  patients  that  present  with  myosteatosis  have  developed  a  chronic  
form  of  the  disorder,  where  lipid  infiltration  and  muscle  wasting  is  already  progressed.  
Persistent  muscle  weakness  and  atrophy  is  a  major  drawback  in  the  ability  to  
successfully  treat  these  injuries  and  reduce  patient  recovery  times.  Therefore,  improving  
the  regeneration  of  skeletal  muscle  following  surgical  intervention  will  decrease  failure  
rates.  Therapies  that  aim  to  increase  beta-­oxidation  will  likely  help  patients  with  acute  
myosteatosis  and  decrease  subsequent  lipid  accumulation.  However,  for  chronic  
situations,  strategies  to  increase  IGF-­1  signaling  would  potentially  be  promising  
therapies  to  increase  muscle  size  and  regeneration  for  chronically  wasted  muscles.  This  
would  require  further  research  towards  specific  therapeutic  targets  and  methods  of  
administration  of  such  therapies  in  order  to  translate  from  pre-­clinical  models  to  human  
treatment.    
CONCLUSIONS  
   Diseases  and  injuries  to  the  musculoskeletal  system  are  the  leading  cause  of  
disability  for  people  in  the  United  States,  and  account  for  over  half  of  chronic  conditions  
for  individuals  over  50  (20).  By  2030,  the  number  of  individuals  over  65  is  expected  to  
double,  therefore  there  will  likely  always  be  a  requirement  for  research  towards  the  
development  of  therapies  for  musculoskeletal  conditions.  The  studies  in  this  dissertation  
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made  considerable  advancements  in  the  understanding  of  musculoskeletal  physiology.  
These  data  will  serve  as  the  framework  to  better  understand  musculoskeletal  conditions  
involving  tendinopathies  and  muscle  myosteatosis,  and  likely  have  a  much  wider  reach  
than  these  disorders.    
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Figure  5.1.  Expression  of  scleraxis  and  tenomodulin  in  a  cohort  (N=2)  of  isolated  
CD146+  cells  in  culture.  Cells  were  passaged  into  3D  type  I  collagen  gel  and  isolated  
3,  6,  and  8  days  following  passaging.  
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Figure  5.2.  Immunohistochemical  images  of  biceps  tendon  biopsies  from  patients  
with  healthy  (left)  or  tendinopathic  (right)  tendon.  Scleraxis  (green),  tubulin  (red),  
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